	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)	CLUSTER	PREPROCESSED_SENTENCE
S103-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]	0	['overall, epidemiological  autoimmune disease, childhood adolescence,  supplementation adulthood reduces sclerosis; therefore, supplementation adolescents young  prevention.6the month birth  supplementation sclerosis utero development.14they multi-hit causal cascade sclerosis, environmental factors,  concentrations, life.53\n\nwhat topic\nin northern hemisphere, cases sclerosis people born born november\nmaternal exposure ambient ultraviolet radiation pregnancy  status pregnancy\nlow  concentrations higher sclerosis\n\nwhat adds\nin australia reciprocal month birth sclerosis, higher born november-december may-june\nthis maternal exposure ambient ultraviolet radiation trimester\nlow maternal exposure ultraviolet radiation trimester sclerosis offspring adjustment place birth\n\npubmed central:']
S296-PMC1448690	PMC1448690	4/2006	S296-PMC1448690	['the dietary factors INVOLVED include Eating at fast food outlets, as well as lower intake of milk, vegetables, fibre and Foods rich in Vitamin E. dietary Vitamin E was REPORTED to inhibit Ige responses to allergic stimuli in a random sample of 2633 Adults [174].']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 168)]	2	[('GO_0051318', 'G1 phase', 37, 'eating'), ('CHEBI_33290', 'food', 121, 'foods'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('GO_0007630', 'jump response', 188, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 188, 'IgE'), ('UBERON_0007023', 'adult organism', 249, 'adults')]	0	['dietary eating fast food outlets, intake milk, vegetables, fibre foods rich vitamin e. dietary  inhibit ige responses allergic stimuli random sample 2633  [174].']
S297-PMC1448690	PMC1448690	4/2006	S297-PMC1448690	['in a study of Adult-onset wheeze in aberdeen, intakes of Vitamin E and Plasma levels of Ascorbate (a measure of vitamin c) were inversely RELATED to Adult wheeze in the manual social class and among current smokers [175].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('UBERON_0007023', 'adult organism', 14, 'adult'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 71, 'plasma'), ('CHEBI_22651', 'ascorbate', 88, 'ascorbate'), ('UBERON_0007023', 'adult organism', 149, 'adult')]	0	['-onset wheeze aberdeen, intakes  plasma levels ascorbate (a measure vitamin c)  wheeze manual social class among smokers [175].']
S302-PMC1448690	PMC1448690	4/2006	S302-PMC1448690	['in a separate study, the lowest intake of Vitamin E was ASSOCIATED with a fivefold increase in Adult-onset wheezy illness, while the lowest intake of vitamin c doubled the risk.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin E'), ('UBERON_0007023', 'adult organism', 95, 'adult')]	0	['separate study, lowest intake  fivefold increase -onset wheezy illness, lowest intake vitamin c doubled risk.']
S26-PMC2290997	PMC2290997	4/2008	S26-PMC2290997	['more RECENTLY, there HAS BEEN a GROWING APPRECIATION for Vitamin D’s IMPACT on bone health in Adults.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adults')]	0	['recently, ’s bone .']
S86-PMC2290997	PMC2290997	4/2008	S86-PMC2290997	['“moreover, there is an inflammatory component to atherosclerosis, and Vascular Smooth Muscle Cells have a Vitamin D receptor and relax in the presence of 1,25(Oh)D, SUGGESTING a multitude of mechanisms by which Vitamin D MAY BE cardioprotective.”\nTO DETERMINE the POTENTIAL LINK betwen sun exposure and the PROTECTIVE effect in preventing hypertension, rolfdieter krause of the free university of berlin department of natural medicine and colleagues exposed a group of hypertensive Adults to a Tanning Bed that emitted full-spectrum uvr similar to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 221), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 307)]	6	[('CL_0000359', 'vascular associated smooth muscle cell', 70, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 70, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 158, '(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('UBERON_0007023', 'adult organism', 482, 'adults'), ('UBERON_0002544', 'digit', 494, 'tanning'), ('UBERON_0002531', 'paired fin bud', 502, 'bed')]	0	['“moreover, inflammatory atherosclerosis, vascular smooth muscle cells  receptor relax presence 1,25(oh)d, multitude mechanisms  cardioprotective.”\nto betwen sun exposure hypertension, rolfdieter krause university berlin department natural medicine colleagues exposed hypertensive  tanning bed emitted full-spectrum uvr summer sunlight.']
S2-PMC2396486	PMC2396486	6/2008	S2-PMC2396486	['because the Nucleus Accumbens HAS BEEN IMPLICATED in neuropsychiatric disorders, in THE CURRENT STUDY we EXAMINED protein Expression in this region in Adult Rats exposed to Dvd deficiency\n\nmethods\nfemale sprague dawley Rats were maintained on a Vitamin D deficient diet for 6 weeks, Mated and allowed to Give Birth, after which a diet containing Vitamin D was reintroduced.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 105)]	4	[('UBERON_0001882', 'nucleus accumbens', 12, 'nucleus accumbens'), ('GO_0010467', 'gene expression', 122, 'expression'), ('UBERON_0007023', 'adult organism', 151, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 157, 'rats'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 173, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 219, 'rats'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007618', 'mating', 283, 'mated'), ('GO_0007631', 'feeding behavior', 304, 'give'), ('GO_0007567', 'parturition', 309, 'birth'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]	0	['nucleus accumbens neuropsychiatric disorders, protein expression region  rats exposed dvd deficiency\n\nmethods\nfemale sprague dawley rats  diet 6 weeks, mated allowed birth, diet containing  reintroduced.']
S29-PMC2821652	PMC2821652	2/2010	S29-PMC2821652	['DESPITE an expanding Intravascular volume during Pregnancy, maternal Vitamin D status SHOWS seasonal variation but beyond the typical FACTORS that INFLUENCE Vitamin D status in Adults (such as sunlight exposure and bmi), Vitamin D status does not fluctuate during Pregnancy and once supplemented, maternal Blood levels reach steady-state within 2 months [15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('GO_0005622', 'intracellular anatomical structure', 21, 'intravascular'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy'), ('UBERON_0000178', 'blood', 306, 'blood')]	0	['despite intravascular volume pregnancy, maternal  status seasonal typical  status  (such sunlight exposure bmi),  status fluctuate pregnancy supplemented, maternal blood levels steady-state 2 months [15].']
S118-PMC2872349	PMC2872349	4/2010	S118-PMC2872349	['a further example of a dynamic INTERACTION between Genetic and environmental INFLUENCES of bone mass was shown in the analysis of the Vitamin D Receptor (vdr) genotype and Adult bmd in participants of the hertfordshire cohort study.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('SO_0000704', 'gene', 51, 'genetic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 134, 'vitamin D receptor'), ('UBERON_0007023', 'adult organism', 172, 'adult')]	0	['example dynamic genetic environmental bone mass  receptor (vdr) genotype  bmd participants hertfordshire study.']
S14-PMC2889879	PMC2889879	5/2010	S14-PMC2889879	['conclusion\nOUR FINDINGS RAISE a POSSIBILITY that Adult women with a high Intake of fish, Omega-3 or Omega-6 Pufa and Vitamin D have a lower rate of psychotic-like symptoms.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('EXPLICIT_QUESTION', 24), ('INCOMPLETE_EVIDENCE', 32)]	3	[('UBERON_0007023', 'adult organism', 49, 'adult'), ('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_79370', 'ibho#10', 89, 'omega-3'), ('CHEBI_79370', 'ibho#10', 100, 'omega-6'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 108, 'PUFA'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]	0	['conclusion\nour  women intake fish, omega-3 omega-6 pufa  rate psychotic-like symptoms.']
S36-PMC2889879	PMC2889879	5/2010	S36-PMC2889879	['HOWEVER, TO OUR KNOWLEDGE, NO STUDY has investigated the ASSOCIATION between dietary Intake of fish, Omega-3 and Omega-6 Pufa or Vitamin D and the risk of having positive psychotic symptoms in the general Adult population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('FULL_UNKNOWN', 27), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('GO_0007631', 'feeding behavior', 85, 'intake'), ('CHEBI_79370', 'ibho#10', 101, 'omega-3'), ('CHEBI_82670', 'ELQ-271', 113, 'omega-6 PUFA'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0007023', 'adult organism', 205, 'adult')]	0	['however, knowledge, dietary intake fish, omega-3 omega-6 pufa  positive psychotic symptoms  population.']
S134-PMC2889879	PMC2889879	5/2010	S134-PMC2889879	['NO earlier STUDIES that we ARE AWARE OF have evaluated the RELATIONSHIP between Adult Vitamin D levels and psychotic symptoms.']	[('FULL_UNKNOWN', 0), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('UBERON_0007023', 'adult organism', 80, 'adult'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]	0	['  levels psychotic symptoms.']
S5-PMC2913107	PMC2913107	8/2010	S5-PMC2913107	['SIMULTANEOUS with the above two acta paediatrica publications, a PAPER elsewhere REPORTED that among 117 Adult psychiatric outpatients is sweden with various diagnoses, the 10 patients with autism had the lowest Vitamin D levels of any of the groups studied, a mean of 12 ng/ml (31 nm), approaching the osteomalacic range for Adults and the Rachitic range for children (6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 81)]	3	[('UBERON_0007023', 'adult organism', 105, 'adult'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('UBERON_0007023', 'adult organism', 326, 'adults'), ('UBERON_0000387', 'meniscus', 341, 'rachitic')]	0	['simultaneous acta paediatrica publications, among 117  psychiatric outpatients sweden diagnoses, 10 patients autism lowest  levels studied, 12 ng/ml (31 nm), approaching osteomalacic  rachitic children (6).']
S48-PMC3075531	PMC3075531	7/2010	S48-PMC3075531	['the ONLY study satisfying this condition used a nested case-control design to sample an underlying prospective cohort comprising over 7 million Individuals who served in the us military and had at least two Serum samples stored in the us department of defense Serum repository.18the study CONCLUDED that Serum concentration of 25 Hydroxyvitamin D in healthy young white Adults is an IMPORTANT PREDICTOR of their risk of developing ms, INDEPENDENTLY from their place of Birth and latitude of residence during childhood.18in a prospective investigation comprising approximately 200,000 women in the usa, Vitamin D intake was measured every 4 years by a comprehensive semi-quantitative Food frequency questionnaire.37the incidence of ms during the 30-year follow-up decreased with increasing Vitamin D intake (p=0.03 for trend) and was 33% lower among women in the highest quintile of Vitamin D intake versus those in the lowest quintile.17furthermore, ms incidence was 41% lower among women taking 400 iu per day or more from Supplements compared with non-users.17ATTEMPTS to RELATE Vitamin D intake to ms risk HAVE also BEEN made in casecontrol studies.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 435), ('INCOMPLETE_EVIDENCE', 1062), ('SUPERFICIAL_RELATIONSHIP', 1074), ('INCOMPLETE_EVIDENCE', 1109)]	8	[('NCBITaxon_1', 'root', 144, 'individuals'), ('UBERON_0001977', 'blood serum', 207, 'serum'), ('UBERON_0001977', 'blood serum', 260, 'Serum'), ('UBERON_0001977', 'blood serum', 304, 'serum'), ('CHEBI_37972', 'phosphorus-32 atom', 327, '25'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 330, 'hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 370, 'adults'), ('GO_0007567', 'parturition', 469, 'birth'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_33290', 'food', 683, 'food'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 882, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 1024, 'supplements'), ('CHEBI_27300', 'vitamin D', 1081, 'vitamin D')]	0	['condition case-control sample comprising 7 million individuals served us military serum samples stored us department defense serum repository.18the serum concentration 25 hydroxyvitamin healthy young white  ms, place birth latitude residence childhood.18in comprising 200,000 women usa,  intake 4 semi-quantitative food frequency questionnaire.37the ms 30-year follow-up decreased  intake (p=0.03 trend) 33% among women quintile  intake lowest quintile.17furthermore, ms 41% among women 400 iu day supplements non-users.17attempts  intake ms casecontrol studies.']
S58-PMC3075531	PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]	0	['therefore, genetic vitamin-d-related genes ms risk, modifying .40\nour ms results longitudinal serum 25-hydroxyvitamin ms onset,18and results  ms, 70% ms cases usa europe serum 25-hydroxyvitamin concentration adolescents young  100 nmol/l.4142these concentrations individuals outdoor lifestyles sunny regions, people 1000-4000 iu colecalciferol daily.8254344although doses outcomes,819confirmation recommendations.']
S0-PMC3257641	PMC3257641	3/2010	S0-PMC3257641	['Vitamin D status during Pregnancy and aspects of offspring health\n\nabstract\nlow maternal Vitamin D levels during Pregnancy HAVE BEEN LINKED to various health outcomes in the offspring, ranging from periconceptional EFFECTS to diseases of Adult onset.']	[('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('UBERON_0007023', 'adult organism', 238, 'adult')]	0	['vitamin status pregnancy aspects offspring health\n\nabstract\nlow maternal  levels pregnancy outcomes offspring, periconceptional diseases  onset.']
S48-PMC3257641	PMC3257641	3/2010	S48-PMC3257641	['a NUMBER OF STUDIES within non-Pregnant Adult populations have examined 25(Oh)D levels in RELATION to DIFFERENT dosages, preparations or dosing intervals of oral Vitamin D (reviewed in[33]).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	3	[('GO_0007565', 'female pregnancy', 31, 'pregnant'), ('UBERON_0007023', 'adult organism', 40, 'adult'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]	0	['non-pregnant  populations 25(oh)d levels dosages, preparations dosing intervals oral  (reviewed in[33]).']
S56-PMC3257641	PMC3257641	3/2010	S56-PMC3257641	['a RECENT meta-analysis of Vitamin D supplementation in RELATION to bone health in Adults, SHOWED that for every 1 iu increase in oral Vitamin D3, the 25(Oh)D level COULD BE expected to increase by 0.016 nmol/l, with a relatively linear RELATIONSHIP AT LEAST up to 2000 iu/day [45].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 236), ('PROBABLE_UNDERSTANDING', 249)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0007023', 'adult organism', 82, 'adults'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]	0	['meta-analysis  supplementation bone iu increase oral vitamin d3, 25(oh)d increase 0.016 nmol/l, linear 2000 iu/day [45].']
S132-PMC3257641	PMC3257641	3/2010	S132-PMC3257641	['this is a DIFFICULT BUT IMPORTANT AREA to research [101,102,103,104], with Animal work indicting transient Prenatal Vitamin D deficiency is ASSOCIATED with subtle alterations in Learning and Memory functions in Adult Rats [105].']	[('DIFFICULT_TASK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('IMPORTANT_CONSIDERATION', 24), ('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 140)]	5	[('NCBITaxon_33208', 'Metazoa', 75, 'animal'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007612', 'learning', 178, 'learning'), ('GO_0007613', 'memory', 191, 'memory'), ('UBERON_0007023', 'adult organism', 211, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 217, 'rats')]	0	['[101,102,103,104], animal indicting transient prenatal  subtle alterations learning memory functions  rats [105].']
S140-PMC3257641	PMC3257641	3/2010	S140-PMC3257641	['seasonal PATTERNS of Birth in Adults [114] and children [115] with Brain tumors and epilepsy [116] HAVE BEEN NOTED and COULD BE evidence of an EFFECT of low Vitamin D status, BUT this is far from CONCLUSIVE.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 99), ('ANOMALY_CURIOUS_FINDING', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196)]	7	[('GO_0007567', 'parturition', 21, 'birth'), ('UBERON_0007023', 'adult organism', 30, 'adults'), ('UBERON_0000955', 'brain', 67, 'brain'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]	0	['seasonal birth  [114] children [115] brain tumors epilepsy [116]  status, conclusive.']
S143-PMC3257641	PMC3257641	3/2010	S143-PMC3257641	['in Adult ecological and observational studies there is considerable EVIDENCE that Vitamin D status MAY BE RELATED to risk or prognosis of a number of cancers, including of the Prostate [121] and Breast [122].']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('UBERON_0007023', 'adult organism', 3, 'adult'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 176, 'prostate'), ('UBERON_0000310', 'breast', 195, 'breast')]	0	[' ecological  status cancers, prostate [121] breast [122].']
S199-PMC3277098	PMC3277098	12/2011	S199-PMC3277098	['most of these OBSERVATIONAL studies DID NOT have direct serological measures of 25(Oh)D levels to ACCURATELY CONFIRM Vitamin D status and cross sectional study designs involving older children and Adults fail TO provide EVIDENCE on aetiological FACTORS.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('UBERON_0007023', 'adult organism', 197, 'adults')]	0	['serological 25(oh)d levels  status older children  aetiological factors.']
S9-PMC3296991	PMC3296991	2/2012	S9-PMC3296991	['in teens and Adults, Parathyroid hormone (pth) and bone specific alkaline phosphatase (balp) are elevated in Vitamin D deficiency and are ASSOCIATED with enhanced bone turnover [2,3].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('UBERON_0007023', 'adult organism', 13, 'adults'), ('UBERON_0001132', 'parathyroid gland', 21, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]	0	['teens parathyroid hormone (pth) bone alkaline phosphatase (balp) elevated  bone turnover [2,3].']
S43-PMC3309463	PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]	0	['developmental  schizophrenia dark-skinned migrants living crowded urban settings.28both dark skin urban residence hypovitaminosis d.29developmental  well-replicated season birth schizophrenia (those born winter spring schizophrenia).30vitamin potent pro-differentiation agent brain functioning via pathways.31the  receptor enzyme manufacture hormonally form  human brain,32and rodent transient prenatal  results changes  brain structure, neurochemistry behavior.33our species settings  abundant, migration colder climates urban-related lifestyle left modern humans hypovitaminosis d.\ninspired above, absence  levels deprives organism instructions environment.']
S82-PMC3347028	PMC3347028	3/2012	S82-PMC3347028	['in nonpregnant adolescents and Adults, increased pth is ASSOCIATED with lower circulating concentrations of ionized calcium, which is MOST OFTEN PRECIPITATED by Vitamin D deficiency and decreased Intestinal calcium absorption.']	[('SUPERFICIAL_RELATIONSHIP', 56), ('PROBABLE_UNDERSTANDING', 134), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('UBERON_0007023', 'adult organism', 31, 'adults'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('UBERON_0000160', 'intestine', 196, 'intestinal')]	0	['nonpregnant adolescents pth circulating concentrations ionized calcium,  decreased intestinal calcium absorption.']
S87-PMC3347028	PMC3347028	3/2012	S87-PMC3347028	['it IS NOT SURPRISING, then that during Pregnancy pth as a MARKER of Vitamin D status is a LESS RELIABLE PREDICTOR than in nonpregnant Adults [60,61,62].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 6), ('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 104)]	7	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]	0	['surprising, pregnancy pth  status nonpregnant  [60,61,62].']
S155-PMC3347028	PMC3347028	3/2012	S155-PMC3347028	['mcgrath and others continue to investigate WHETHER there are lasting EFFECTS of fetal and early infancy Vitamin D deficiency on later Adult disease processes such as Anatomical changes of the Brain, schizophrenia, multiple sclerosis, certain cancers, Cardiovascular disease, and various other Autoimmune diseases such as diabetes and lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adult'), ('UBERON_0001062', 'anatomical entity', 166, 'anatomical'), ('UBERON_0000955', 'brain', 192, 'brain'), ('UBERON_0004535', 'cardiovascular system', 251, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 293, 'autoimmune')]	0	['mcgrath lasting fetal infancy   disease processes anatomical changes brain, schizophrenia, sclerosis, cancers, cardiovascular disease, autoimmune diseases diabetes lupus [106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121].']
S174-PMC3347028	PMC3347028	3/2012	S174-PMC3347028	['one does not become Vitamin D toxic from sunlight exposure; HOWEVER, in comparison, People have become toxic from Ingesting too much oral Vitamin D. in an Adult, it APPEARS that the upper limit of tolerability of Vitamin D is a daily consumption of thousands of international units of Vitamin D—above 10,000 iu/day [142,143].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ANOMALY_CURIOUS_FINDING', 165)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'people'), ('GO_0007567', 'parturition', 114, 'ingesting'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]	0	['one  toxic sunlight exposure; however, comparison, people toxic ingesting oral . upper tolerability  daily consumption thousands international units —above 10,000 iu/day [142,143].']
S179-PMC3347028	PMC3347028	3/2012	S179-PMC3347028	['a large proportion of the younger Adult population MAY follow these guidelines, which MAY increase the RISK of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 103)]	3	[('UBERON_0007023', 'adult organism', 34, 'adult'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]	0	['proportion younger  population guidelines, increase  deficiency.']
S18-PMC3348565	PMC3348565	4/2012	S18-PMC3348565	['HOWEVER, the risk of repeated pneumonia in the subsequent 3 months was 13% (relative risk [rr] 0·78, 95% ci 0·64–0·94; p=0·01) lower in the Vitamin D3Compared with the placebo group.3OTHER more RECENT STUDIES assessing different outcomes in children or Adults have CONFLICTING findings on the effectiveness of Vitamin D.\nthere is GROWING EVIDENCE of the Vitamin D parancrine system enhancing Innate Immunity:4the activation of toll-like receptors on Monocytes and Macrophages by Microbial pathogens results in increased Expression of Cyp27B1 and Vitamin D Receptor ( vdr ) Genes within these cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('INCOMPLETE_EVIDENCE', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('INCOMPLETE_EVIDENCE', 330)]	6	[('CHEBI_59884', 'XDP(3-)', 140, 'vitamin D3compared'), ('UBERON_0007023', 'adult organism', 253, 'adults'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0045087', 'innate immune response', 392, 'innate immunity'), ('CL_0000576', 'monocyte', 450, 'monocytes'), ('CL_0000235', 'macrophage', 464, 'macrophages'), ('NCBITaxon_10088', 'Mus <genus>', 479, 'microbial'), ('GO_0010467', 'gene expression', 520, 'expression'), ('PR_000006101', 'cytochrome P450 1A1', 534, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 546, 'vitamin D receptor'), ('SO_0000704', 'gene', 573, 'genes')]	0	['however, pneumonia 3 months 13% (relative [rr] 0·78, 95% ci 0·64–0·94; p=0·01) vitamin d3compared placebo group.3other outcomes children  .\nthere  parancrine system innate immunity:4the activation toll-like receptors monocytes macrophages microbial pathogens results expression cyp27b1  receptor vdr genes cells.']
S128-PMC3348565	PMC3348565	4/2012	S128-PMC3348565	['the optimum concentrations of Vitamin D for Adults and children6are BASED ON non-immunological and, MOSTLY, bone outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 100)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0007023', 'adult organism', 44, 'adults')]	0	['concentrations   children6are non-immunological and, mostly, bone outcomes.']
S38-PMC3356951	PMC3356951	4/2012	S38-PMC3356951	['the MAJOR source of Vitamin D for children and Adults is exposure to natural sunlight.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0007023', 'adult organism', 47, 'adults')]	0	[' children  exposure natural sunlight.']
S74-PMC3356951	PMC3356951	4/2012	S74-PMC3356951	['[1293360] Vitamin D produced in the skin MAY last AT LEAST twice as long in the Blood compared with Ingested Vitamin D.[61] when an Adult wearing a bathing suit is exposed to one minimal erythemal dose of uv radiation (a slight pinkness to the skin 24 h after exposure), the amount of vitamin d produced is equivalent to Ingesting between 10,000 and 25,000 iu.']	[('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 50)]	2	[('CHEBI_28384', 'vitamin K', 10, 'Vitamin D'), ('UBERON_0000178', 'blood', 80, 'blood'), ('GO_0007631', 'feeding behavior', 100, 'ingested'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult'), ('GO_0007567', 'parturition', 321, 'ingesting')]	0	['[1293360] vitamin skin last twice blood ingested .[61]  wearing bathing suit exposed erythemal dose uv radiation (a pinkness skin 24 h exposure), amount vitamin ingesting 10,000 25,000 iu.']
S128-PMC3356951	PMC3356951	4/2012	S128-PMC3356951	['[6] MANY STUDIES HAVE SHOWN an ASSOCIATION between low Vitamin D concentrations and an INCREASED RISK of fractures and falls in older Adults.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 87)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]	0	['[6]  concentrations fractures falls older .']
S146-PMC3356951	PMC3356951	4/2012	S146-PMC3356951	"['[""""[103]\\n\\nrecommended dietary intakes of Vitamin D\\nescp SUGGESTS that obese children and Adults on Anticonvulsant medications, Glucocorticoids, antifungals such as Ketoconazole, and medications for aids SHOULD BE given at least two to three times more Vitamin D for their age group to satisfy their body\'s Vitamin D REQUIREMENT[table 1].""""]']"	[('INCOMPLETE_EVIDENCE', 53), ('FUTURE_WORK', 200), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 313)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adults'), ('CHEBI_35624', 'azaspiro compound', 96, 'anticonvulsant'), ('CHEBI_36597', 'phthalazine', 124, 'glucocorticoids'), ('CHEBI_47519', 'ketoconazole', 161, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]	0	"['[""""[103]\\n\\nrecommended dietary intakemin d\\nescp obese childreadults anticonvulsant medications, glucocorticoids, antifungals ketoconazole, medications three timesamin age bamin requirement[table 1].""""]']"
S36-PMC3395583	PMC3395583	7/2012	S36-PMC3395583	['average monthly 25-Oh-D levels were collected from a large cohort of Adult scottish and english women (n = 3,787) as previously described [28] and used as a PROXY for the seasonal variation in Gestational Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 157)]	1	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 16, '25-OH-D'), ('UBERON_0007023', 'adult organism', 69, 'adult'), ('GO_0007565', 'female pregnancy', 193, 'gestational'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]	0	['average monthly 25-oh-d levels  scottish english women (n = 3,787) [28] seasonal gestational  status.']
S97-PMC3403156	PMC3403156	7/2012	S97-PMC3403156	['Prenatal Vitamin C inhibited the hypoxia-induced increase in fetal Cardiac Hsp70 Expression and Adult Myocardial contractility ASSOCIATED with Β 1 Adrenoceptor stimulation in Rat offspring [36].']	[('SUPERFICIAL_RELATIONSHIP', 127)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('UBERON_0000948', 'heart', 67, 'cardiac'), ('PR_000008794', 'heat shock factor protein 5', 75, 'HSP70'), ('GO_0010467', 'gene expression', 81, 'expression'), ('UBERON_0007023', 'adult organism', 96, 'adult'), ('UBERON_0002349', 'myocardium', 102, 'myocardial'), ('PR_000001595', 'leukotriene B4 receptor 2', 143, 'β 1 adrenoceptor'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 175, 'rat')]	0	['prenatal  inhibited hypoxia-induced increase fetal cardiac hsp70 expression  myocardial contractility β adrenoceptor stimulation rat offspring [36].']
S98-PMC3407995	PMC3407995	7/2012	S98-PMC3407995	['promote normal Brain Development—PRELIMINARY RESEARCH SUGGESTS that Gestational Vitamin D insufficiency HAS BEEN LINKED to altered Brain Development and Adult mental health [49], in particular schizophrenia [54].']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('GO_0007420', 'brain development', 15, 'brain development'), ('UBERON_0000955', 'brain', 15, 'brain'), ('GO_0007565', 'female pregnancy', 68, 'gestational'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007420', 'brain development', 131, 'brain development'), ('UBERON_0000955', 'brain', 131, 'brain'), ('UBERON_0007023', 'adult organism', 153, 'adult')]	0	['promote normal brain development—preliminary gestational  altered brain  mental [49], schizophrenia [54].']
S278-PMC3407995	PMC3407995	7/2012	S278-PMC3407995	['DESPITE abundant sunshine and latitude CONSISTENT with year-long Vitamin D Synthesis, 65.5% of a largely low-risk Antenatal population in rural victoria, australia had insufficient Vitamin D. over 5.0% of women had Vitamin D levels that pose a significant neonatal and Adult health RISK [135].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 282)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 65, 'vitamin D synthesis'), ('GO_0007567', 'parturition', 114, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 114, 'antenatal'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0007023', 'adult organism', 269, 'adult')]	0	['despite abundant sunshine latitude year-long  synthesis, 65.5% low-risk antenatal population rural victoria, australia . 5.0% women  levels neonatal  [135].']
S444-PMC3407995	PMC3407995	7/2012	S444-PMC3407995	['there HAS BEEN little toxicity REPORTED in Adults taking doses of Vitamin D as high as 10,000 iu/day (250 µg/day) of Vitamin d [176,177,178] ALTHOUGH toxicity becomes GENERALLY present at 20,000 iu/day (500 µg/day).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 141), ('PROBABLE_UNDERSTANDING', 167)]	4	[('UBERON_0007023', 'adult organism', 43, 'adults'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 117, 'vitamin')]	0	['toxicity  doses  10,000 iu/day (250 µg/day) vitamin [176,177,178] toxicity becomes 20,000 iu/day (500 µg/day).']
S53-PMC3427192	PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]	0	['vitamin  asthma\nin dietary intake  ranges 600 800 iu daily.47however, foods supplemented proportion  population  deficient,77,78perhaps sun exposure obesity decreased  bioavailability.79similar school age children, cross-sectional   status asthma (table 3).']
S56-PMC3427192	PMC3427192	4/2012	S56-PMC3427192	['ultimately, randomized controlled trials of Vitamin D ARE NEEDED in Adults with asthma to determine the causal ASSOCIATIONS between Vitamin D and asthma and to develop an evidence base for treatment.']	[('FUTURE_WORK', 54), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0007023', 'adult organism', 68, 'adults'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]	0	['ultimately,   asthma causal  asthma treatment.']
S58-PMC3427192	PMC3427192	4/2012	S58-PMC3427192	['THUS, Vitamin D MAY have therapeutic EFFECTIVENESS in Adults with asthma, but MORE STUDIES ARE CLEARLY NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 78), ('FUTURE_WORK', 83)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adults')]	0	['thus,   asthma, needed.']
S60-PMC3427192	PMC3427192	4/2012	S60-PMC3427192	['studies of Vitamin D status in Adults with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher Serum 25(Oh)D ASSOCIATED with increased Lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, history of asthma, and asthma exacerbationhigher serum 25(Oh)D ASSOCIATED with decreased odds of current wheezing and asthma as well as emergency visits for asthma and asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, total Serum igehigher 25(Oh)D ASSOCIATED with greater Lung function with no associations NOTED for igeoren832008290 (26)43cross-sectionalobese patientsasthma and allergic rhinitis25(Oh)D deficiency (< 25 ng/ml) ASSOCIATED with increased odds of atopic dermatitis BUT no associations with asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, Airway hyper-responsiveness, Glucocorticoid responsivenessdecreased 25(Oh)D ASSOCIATED with decreased Lung function, increased Airway hyperresponsiveness, and reduced Glucocorticoid responses\n\ngenetics of Vitamin D and asthma\nSOME STUDIES have FOCUSED on Genetic ASSOCIATIONS between Vitamin D and asthma in larger populations.']	[('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 388), ('SUPERFICIAL_RELATIONSHIP', 620), ('ANOMALY_CURIOUS_FINDING', 679), ('SUPERFICIAL_RELATIONSHIP', 801), ('ANOMALY_CURIOUS_FINDING', 853), ('SUPERFICIAL_RELATIONSHIP', 1034), ('INCOMPLETE_EVIDENCE', 1184), ('QUESTION_ANSWERED_BY_THIS_WORK', 1202), ('SUPERFICIAL_RELATIONSHIP', 1221)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0007023', 'adult organism', 31, 'adults'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 211, '25(OH)D'), ('UBERON_0002048', 'lung', 245, 'lung'), ('CHEBI_71657', 'versiconol acetate', 380, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 380, '25(OH)D'), ('UBERON_0001977', 'blood serum', 596, 'serum'), ('CHEBI_71657', 'versiconol acetate', 612, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 612, '25(OH)D'), ('UBERON_0002048', 'lung', 644, 'lung'), ('CHEBI_33010', 'chromide(1-)', 771, '(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 775, 'D'), ('UBERON_0001005', 'respiratory airway', 958, 'airway'), ('CHEBI_24261', 'glucocorticoid', 987, 'glucocorticoid'), ('CHEBI_71657', 'versiconol acetate', 1026, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 1029, 'OH ... D'), ('UBERON_0002048', 'lung', 1060, 'lung'), ('UBERON_0001005', 'respiratory airway', 1085, 'airway'), ('CHEBI_24261', 'glucocorticoid', 1125, 'glucocorticoid'), ('CHEBI_28384', 'vitamin K', 1163, 'Vitamin D'), ('SO_0000704', 'gene', 1213, 'genetic'), ('CHEBI_27300', 'vitamin D', 1242, 'vitamin D')]	0	['studies  status  designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher serum 25(oh)d lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, asthma, asthma exacerbationhigher serum 25(oh)d decreased wheezing asthma visits asthma asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, serum igehigher 25(oh)d lung igeoren832008290 (26)43cross-sectionalobese patientsasthma allergic rhinitis25(oh)d (< 25 ng/ml) atopic dermatitis asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, airway hyper-responsiveness, glucocorticoid responsivenessdecreased 25(oh)d decreased lung function, airway hyperresponsiveness, glucocorticoid responses\n\ngenetics vitamin asthma\nsome genetic  asthma populations.']
S95-PMC3427250	PMC3427250	8/2012	S95-PMC3427250	['a previous small study in brussels SUGGESTED that the prevalence of Vitamin D deficiency was high among the Adult population and that immigrants were at greater risk of Vitamin D deficiency[32].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 108, 'adult'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]	0	['brussels  among  population immigrants  deficiency[32].']
S103-PMC3427250	PMC3427250	8/2012	S103-PMC3427250	['ethnicity was also a major DETERMINANT of Vitamin D status in the PRESENT STUDY, as PREVIOUSLY reported in the Adult population[32]and in Pregnant women[29],[48],[49].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('INCOMPLETE_EVIDENCE', 84)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 138, 'pregnant')]	0	['ethnicity  status study,  population[32]and pregnant women[29],[48],[49].']
S24-PMC3432839	PMC3432839	8/2012	S24-PMC3432839	['HOWEVER, they MAY BE an INDICATOR of increased risk of arthritis in Adulthood, SINCE it HAS BEEN SHOWN that children with Limb pains are more LIKELY to have parents and/or grandparents with a history of arthritis COMPARED TO the general population.1among SMALL STUDIES of selected groups of children, recurrent Limb pains HAVE BEEN REPORTED to be PARTICULARLY PREVALENT in obese children,4and in those with some Vitamin D deficiency,5THOUGH this WAS NOT FOUND in a SMALL STUDY in new mexico.6other POSSIBILITIES HAVE BEEN summarised by evans and scutter.7\nAdult arthritis HAS long BEEN CONSIDERED to be a condition that COULD BE ameliorated or prevented by dietary manipulation, with SUGGESTIONS of different components of the diet being IMPORTANT—particularly Ω-3 Fatty Acids.8TO OUR KNOWLEDGE the ONLY specific dietary factor that has BEEN CONSIDERED in regard to childhood Limb pain concerns a study of 532 greek children aged 4–12.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 322), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 347), ('IMPORTANT_CONSIDERATION', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 433), ('INCOMPLETE_EVIDENCE', 446), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 454), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 572), ('INCOMPLETE_EVIDENCE', 586), ('INCOMPLETE_EVIDENCE', 620), ('INCOMPLETE_EVIDENCE', 684), ('IMPORTANT_CONSIDERATION', 738), ('PROBABLE_UNDERSTANDING', 777), ('INCOMPLETE_EVIDENCE', 799), ('ANOMALY_CURIOUS_FINDING', 837), ('INCOMPLETE_EVIDENCE', 842)]	27	[('UBERON_0000113', 'post-juvenile adult stage', 68, 'adulthood'), ('UBERON_0002101', 'limb', 122, 'limb'), ('UBERON_0002101', 'limb', 311, 'limb'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin D'), ('UBERON_0007023', 'adult organism', 556, 'Adult'), ('CHEBI_18320', '1,4-dithiothreitol', 761, 'ω-3'), ('CHEBI_35366', 'fatty acid', 765, 'fatty acids'), ('UBERON_0002101', 'limb', 876, 'limb')]	0	['however, arthritis adulthood, children limb pains parents and/or grandparents arthritis population.1among selected children, recurrent limb pains obese children,4and  deficiency,5though mexico.6other summarised evans scutter.7\n arthritis condition ameliorated dietary manipulation, diet important—particularly ω-3 fatty acids.8to dietary regard childhood limb pain 532 greek children aged 4–12.']
S175-PMC3465343	PMC3465343	10/2012	S175-PMC3465343	['HOWEVER, in OUR STUDY, we used the modified ain-93g diet without any source of Vitamin A and the mean Serum Retinol concentration in the Adult females in the vad group was 0.51±0.57 µmol/l, which was significantly lower than that of the control group (p<0.01).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('UBERON_0007023', 'adult organism', 137, 'adult')]	0	['however, study, ain-93g diet  serum retinol concentration  females vad 0.51±0.57 µmol/l, (p<0.01).']
S0-PMC3472720	PMC3472720	8/2012	S0-PMC3472720	['Prenatal Vitamin D deficiency INDUCES an early and more SEVERE experimental Autoimmune encephalomyelitis in the second generation\n\nabstract\nin a PREVIOUS STUDY, we DEMONSTRATED that Mouse Adult f1offspring, exposed to a Vitamin D deficiency during Pregnancy, developed a less SEVERE and delayed experimental Autoimmune encephalomyelitis (eae), when compared with control offspring.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 145), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 276)]	5	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0005445', 'segment of pes', 76, 'Autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mouse'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy'), ('UBERON_0005445', 'segment of pes', 308, 'Autoimmune')]	0	['prenatal vitamin autoimmune encephalomyelitis generation\n\nabstract\nin study, mouse  f1offspring, exposed  pregnancy, delayed autoimmune encephalomyelitis (eae), offspring.']
S13-PMC3472720	PMC3472720	8/2012	S13-PMC3472720	['in this MODEL, the Vitamin D deficiency experienced by the offspring is restored by the 1st week of Life, therefore the MODEL is not associated with any abnormal Bone Development and calcium and pth levels in the Adult offspring are normal [13].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('GO_0048539', 'bone marrow development', 162, 'bone development'), ('UBERON_0007023', 'adult organism', 213, 'adult')]	0	['model,  experienced offspring restored 1st week life, abnormal bone calcium pth levels  offspring normal [13].']
S18-PMC3476426	PMC3476426	8/2012	S18-PMC3476426	['long-lasting depletion of Vitamin D causes rickets and osteomalacia, with Skeletal deformities in children and bone pain and INCREASED RISK of fractures in Adults, respectively [3].']	[('IMPORTANT_CONSIDERATION', 125)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0004288', 'skeleton', 74, 'skeletal'), ('UBERON_0007023', 'adult organism', 156, 'adults')]	0	['long-lasting depletion  causes rickets osteomalacia, skeletal deformities children bone pain fractures respectively [3].']
S55-PMC3613945	PMC3613945	2/2013	S55-PMC3613945	['similarly, in a study population of 98 healthy Adult women, we FOUND that the 436kk homozygotes exhibited reduced baseline Vitamin D Serum levels44.']	[('INCOMPLETE_EVIDENCE', 63)]	1	[('UBERON_0007023', 'adult organism', 47, 'adult'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0001977', 'blood serum', 133, 'serum')]	0	['similarly, population 98 healthy  women, 436kk homozygotes baseline  serum levels44.']
S39-PMC3672018	PMC3672018	5/2013	S39-PMC3672018	['SOME STUDIES have FOUND that Adult obesity varies as a function of month of Birth and that subjects Born from winter to spring become more obese, POSSIBLY due to low Vitamin D levels from restricted maternal sun exposure during the third Trimester of Pregnancy [16].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 146)]	3	[('UBERON_0007023', 'adult organism', 29, 'adult'), ('GO_0007567', 'parturition', 76, 'birth'), ('GO_0007567', 'parturition', 100, 'born'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 238, 'trimester'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]	0	[' obesity month birth subjects born winter spring obese,  levels maternal sun exposure third trimester pregnancy [16].']
S44-PMC3672018	PMC3672018	5/2013	S44-PMC3672018	['BOTH STUDIES SUGGEST that Prenatal malnutrition strongly IMPACTS Adult health, ALTHOUGH neither INDICATES specific EFFECTS from the lack of Vitamin D. the EFFECT of Vitamin D levels during Gestation, THUS, has never previously been followed in large populations.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 155), ('PROBABLE_UNDERSTANDING', 200)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('UBERON_0007023', 'adult organism', 65, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'gestation')]	0	['prenatal malnutrition  health, .  levels gestation, thus, followed populations.']
S79-PMC3679329	PMC3679329	6/2013	S79-PMC3679329	['a population based cohort study of Adults in the us DEMONSTRATED that supplement users, COMPARED TO non-users, GENERALLY had higher average Intakes of Foods which are IMPORTANT sources of Vitamin C and Carotenoids (i.e., fruits and certain vegetables) [12].']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 167)]	4	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('GO_0007631', 'feeding behavior', 140, 'intakes'), ('CHEBI_33290', 'food', 151, 'foods'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin C'), ('CHEBI_50815', 'norgestimate', 202, 'carotenoids')]	0	['population  us supplement users, non-users, higher average intakes foods sources  carotenoids (i.e., fruits vegetables) [12].']
S81-PMC3679329	PMC3679329	6/2013	S81-PMC3679329	['also SHOWED that non-Pregnant, non-Lactating Adults who were regular users of any type of Supplement consumed more vegetables and fruits, especially those high in Vitamin C [20].']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('GO_0007594', 'puparial adhesion', 35, 'lactating'), ('UBERON_0007023', 'adult organism', 45, 'adults'), ('CHEBI_16158', 'steroid sulfate', 90, 'supplement'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin C')]	0	['also non-pregnant, non-lactating  users type supplement consumed vegetables fruits,  [20].']
S0-PMC3685533	PMC3685533	6/2013	S0-PMC3685533	['Vitamin D status in Cord Blood and newborns: ethnic differences\n\nabstract\n\nbackground\na deficiency in Vitamin D (25Ohd) is common throughout the world in both Adults and children, being RELATED to skin pigmentation, sun exposure, dietary intake and obesity.']	[('SUPERFICIAL_RELATIONSHIP', 186)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 113, '25OHD'), ('UBERON_0007023', 'adult organism', 159, 'adults')]	0	['vitamin status cord blood newborns: ethnic differences\n\nabstract\n\nbackground\na  (25ohd) throughout world  children, skin pigmentation, sun exposure, dietary intake obesity.']
S18-PMC3685533	PMC3685533	6/2013	S18-PMC3685533	['current data within the literature DEMONSTRATES a high prevalence of Vitamin D insufficiency not ONLY in Adult and in children, BUT ALSO in Pregnant women and in their neonates [3-5].']	[('INCOMPLETE_EVIDENCE', 35), ('ANOMALY_CURIOUS_FINDING', 97), ('ANOMALY_CURIOUS_FINDING', 128)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('GO_0007565', 'female pregnancy', 140, 'pregnant')]	0	['current   children, pregnant women neonates [3-5].']
S13-PMC3702245	PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]	0	['however, sustained  results rickets children osteomalacia .28the  nutrition serum 25(oh)d concentrations, 25(oh)d parathyroid hormone, intestinal calcium absorption, skeletal integrity.29while serum parathyroid hormone 25(oh)d nonpregnant states, pregnancy,6,18,30,31indicating serum parathyroid hormone maternal  status pregnancy serum 25(oh)d.32the maternal 25(oh)d pregnancy  intake endogenous synthesis.2,33,34however, serum 1,25(oh)2d levels increase 100%–200% trimester mother fetus.35–37the increase maternal 1,25(oh)2d, originates kidneys, intestinal calcium absorption pregnancy.38,39the increase fetal 1,25(oh)2d synthesis placental fetal tissues.39,40\nan aspect  nutrition pregnancy  status infant birth infancy vitamin status mother pregnancy.41vitamin stores infant transplacental transfer 25(oh)d pregnancy mother fetus.']
S16-PMC3702245	PMC3702245	6/2013	S16-PMC3702245	['high prevalence of low Vitamin D intake in Pregnancy\nthe Vitamin D status in Adults, including Pregnant women, is based currently on measurement of Serum 25(Oh)D concentrations, BUT WHAT constitutes the “normal” OR “optimal” level is CONTROVERSIAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 178), ('EXPLICIT_QUESTION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 77, 'adults'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('CHEBI_63056', 'zinc cation', 154, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 160, 'D')]	0	['high  intake pregnancy\nthe  status pregnant women, serum 25(oh)d concentrations, “normal” “optimal” controversial.']
S17-PMC3702245	PMC3702245	6/2013	S17-PMC3702245	['the institute of medicine in the us in its RECENT report RECOMMENDS that a Serum 25(Oh)D concentration of 50 nmol/l (20 ng/ml) is adequate for calcium absorption and bone health in Adults, including Pregnant women, in the us and canada.7HOWEVER, new clinical guidelines from the endocrine society RECOMMEND maintaining a Serum 25(Oh)D concentration >75 nmol/l (30 ng/ml) in order to maximize calcium absorption and bone health, and for POTENTIAL Extraskeletal benefits noted in observational studies.8many RECENT STUDIES13,15–17,48–57that evaluated Vitamin D nutrition during Pregnancy in different geographic locations REPORTED wide VARIATION in Vitamin D status depending on latitude, season, sunlight exposure behavior, and Vitamin D intake (table 1).']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 297), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 506), ('INCOMPLETE_EVIDENCE', 620), ('DIFFICULT_TASK', 634)]	8	[('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 81, '25(OH)D'), ('UBERON_0007023', 'adult organism', 181, 'adults'), ('GO_0007565', 'female pregnancy', 199, 'pregnant'), ('UBERON_0001977', 'blood serum', 321, 'serum'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 327, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 446, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 576, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin D')]	0	['institute medicine us serum 25(oh)d concentration 50 nmol/l (20 ng/ml) calcium absorption bone pregnant women, us canada.7however, endocrine society maintaining serum 25(oh)d concentration >75 nmol/l (30 ng/ml) maximize calcium absorption bone health, extraskeletal studies.8many studies13,15–17,48–57that  nutrition pregnancy geographic locations  status latitude, season, sunlight exposure behavior,  intake (table 1).']
S21-PMC3702245	PMC3702245	6/2013	S21-PMC3702245	['a Serum 25(Oh)D concentration <25 nmol/l (10 ng/ml), which is ASSOCIATED with INCREASED RISK of osteomalacia in Adults,7is common during Pregnancy, AS INDICATED by RECENT REPORTS from many parts of the world.1for example, Serum 25(Oh)D < 25 nmol/l during Pregnancy HAS BEEN REPORTED in 17%–18% of the caucasian population in the uk,48,4961% of a mixed population in new zealand,5432%–42% in the indian population,15,4559%–84% of a nonwestern population in the netherlands,1441% of the kuwaiti population,1680% of the iranian population,17and 75% of the arab population in the united arab emirates.1HOWEVER, there are LIMITED STUDIES on the ASSOCIATION between such low levels of Vitamin D status and Skeletal integrity in Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 78), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 265), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 597), ('INCOMPLETE_EVIDENCE', 617), ('SUPERFICIAL_RELATIONSHIP', 640)]	10	[('UBERON_0001977', 'blood serum', 2, 'serum'), ('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 8, '25(OH)D'), ('UBERON_0007023', 'adult organism', 112, 'adults'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 679, 'vitamin D'), ('UBERON_0004288', 'skeleton', 700, 'skeletal'), ('GO_0007565', 'female pregnancy', 722, 'pregnant')]	0	['serum 25(oh)d concentration <25 nmol/l (10 ng/ml), osteomalacia ,7is pregnancy, parts world.1for example, serum 25(oh)d 25 nmol/l pregnancy 17%–18% caucasian population uk,48,4961% population zealand,5432%–42% indian population,15,4559%–84% nonwestern population netherlands,1441% kuwaiti population,1680% iranian population,17and 75% arab population united arab emirates.1however, levels  status skeletal integrity pregnant women.']
S72-PMC3702245	PMC3702245	6/2013	S72-PMC3702245	['the institute of MEDICINE7CONSIDERS a Serum 25(Oh)D concentration >50 nmol/l AS acceptable, WHILE the Endocrine society and Vitamin D EXPERTS RECOMMEND >75 nmol/l.8,99a RECENT STUDY among traditional populations in tanzania with type vi (dark) skin color living in a sun-abundant environment RECOMMENDED a mean Serum 25(Oh)D concentration of 115 nmol/l in nonpregnant Adults and 139 nmol/l in Pregnant women.57the question then is: WHAT Serum concentration of 25(Oh)D is “normal” in Adults, including during Pregnancy?']	[('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 134), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 169), ('FUTURE_WORK', 292), ('EXPLICIT_QUESTION', 432), ('EXPLICIT_QUESTION', 517)]	9	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 102, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'serum'), ('CHEBI_71657', 'versiconol acetate', 317, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 317, '25(OH)D'), ('UBERON_0007023', 'adult organism', 368, 'adults'), ('GO_0007565', 'female pregnancy', 393, 'pregnant'), ('UBERON_0001977', 'blood serum', 437, 'serum'), ('CHEBI_71657', 'versiconol acetate', 460, '25(OH)D'), ('UBERON_0007023', 'adult organism', 483, 'adults'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy')]	0	['institute serum 25(oh)d concentration >50 nmol/l acceptable, endocrine society  >75 nmol/l.8,99a among populations tanzania type vi (dark) skin color living sun-abundant environment serum 25(oh)d concentration 115 nmol/l nonpregnant  139 nmol/l pregnant women.57the is: serum concentration 25(oh)d “normal” pregnancy?']
S74-PMC3702245	PMC3702245	6/2013	S74-PMC3702245	['in studies of Adults and nonpregnant women, a Vitamin D intake of up to 10,000 iu/day is ASSOCIATED with achievement of a Serum 25(Oh)D concentration ≥80 nmol/l without Vitamin D toxicity.103,104from a review of PREVIOUS STUDIES, an additional daily intake of 100 iu of Vitamin D increases the Serum 25(Oh)D concentration by 1–2 nmol/l.7,105THEREFORE, knowing the population baseline Serum 25(Oh)D concentration, IT IS POSSIBLE to ESTIMATE the Vitamin D intake REQUIRED to replete body stores and achieve an expected target Serum 25(Oh)d concentration.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 212), ('PROBABLE_UNDERSTANDING', 338), ('INCOMPLETE_EVIDENCE', 413), ('INCOMPLETE_EVIDENCE', 431), ('IMPORTANT_CONSIDERATION', 461)]	6	[('UBERON_0007023', 'adult organism', 14, 'adults'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 122, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 131, 'OH)D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('UBERON_0001977', 'blood serum', 294, 'serum'), ('CHEBI_71657', 'versiconol acetate', 300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 300, '25(OH)D'), ('UBERON_0001977', 'blood serum', 384, 'serum'), ('CHEBI_33010', 'chromide(1-)', 392, '(OH)D'), ('CHEBI_27300', 'vitamin D', 444, 'vitamin D'), ('UBERON_0001977', 'blood serum', 524, 'serum'), ('CHEBI_30778', 'gallic acid', 530, '25(OH)')]	0	[' nonpregnant women,  intake 10,000 iu/day achievement serum 25(oh)d concentration ≥80 nmol/l  toxicity.103,104from studies, daily intake 100 iu  serum 25(oh)d concentration 1–2 nmol/l.7,105therefore, population baseline serum 25(oh)d concentration,  intake replete stores achieve serum 25(oh)d concentration.']
S24-PMC3704911	PMC3704911	7/2013	S24-PMC3704911	['additionally, Prenatal DEFICIENCIES in Vitamins D and E HAVE BEEN ASSOCIATED with increased incidences of Respiratory difficulties, including wheezing and asthma, in the offspring [7], and maternal Vitamin D deficiencies HAVE BEEN RELATED to observed hyper-Locomotion in the Adult Rat [8].']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamins D'), ('PR_000006444', 'diacylglycerol kinase delta', 48, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 54, 'E'), ('UBERON_0001004', 'respiratory system', 106, 'respiratory'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0040011', 'locomotion', 257, 'locomotion'), ('UBERON_0007023', 'adult organism', 275, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 281, 'rat')]	0	['additionally, prenatal  e incidences respiratory difficulties, wheezing asthma, offspring [7], maternal  hyper-locomotion  rat [8].']
S40-PMC3713405	PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]	0	['• schizophrenia\nneurodevelopmental disorder altered dopamine disease onset\n• developmental  (dvd) deficiency\nassociated schizophrenia\n• dvd rat model\ndvd-deficiency rat altered developmental  dopaminergic function\n• vitamin dopamine\nearly  signaling intrinsically dopamine system\n• animal schizophrenia\nmultiple animal schizophrenia alterations dopamine post-adolescent alterations behavior\n• dopamine schizophrenia\nalthough dopamine endpoint schizophrenia, dopaminergic origins be\n\nthe epidemiology vitamin schizophrenia\nnumerous pieces epidemiological levels maternal  schizophrenia.']
S51-PMC3713405	PMC3713405	7/2013	S51-PMC3713405	['to establish the biological PLAUSIBILITY of WHETHER Dvd deficiency COULD BE RELATED to schizophrenia, our group ESTABLISHED a Dvd-deficient Rat MODEL which HAS SHOWN that low Prenatal Vitamin D adversely AFFECTS Brain Development and Adult behavior, ESPECIALLY da development and da-RELATED behaviors.']	[('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 204), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 283)]	10	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 52, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 140, 'rat'), ('GO_0007565', 'female pregnancy', 175, 'prenatal'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007420', 'brain development', 212, 'brain development'), ('UBERON_0000955', 'brain', 212, 'brain'), ('UBERON_0007023', 'adult organism', 234, 'adult')]	0	['biological dvd schizophrenia, dvd-deficient rat prenatal  adversely brain  behavior, da da-related behaviors.']
S133-PMC3713405	PMC3713405	7/2013	S133-PMC3713405	['the mechanism for HOW the developmental absence of Vitamin D MAY INFLUENCE Da Signaling in the Adult REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 18), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 101)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0038162', 'erythropoietin-mediated signaling pathway', 75, 'DA signaling'), ('UBERON_0007023', 'adult organism', 95, 'adult')]	0	['developmental absence  da signaling  unknown.']
S1-PMC3739737	PMC3739737	8/2013	S1-PMC3739737	['the AIM of THIS STUDY was TO INVESTIGATE the EFFECTS of Adult Vitamin D (avd) deficiency on behavioural tasks of relevance to neuropsychiatric disorders in male sprague-dawley Rats.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('UBERON_0007023', 'adult organism', 56, 'adult'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 176, 'rats')]	0	['  (avd) behavioural tasks neuropsychiatric disorders male sprague-dawley rats.']
S14-PMC3739737	PMC3739737	8/2013	S14-PMC3739737	['introduction\nVitamin D deficiency is PREVALENT in the Adult population[1]and there is a GROWING body of EVIDENCE SHOWING that Vitamin D has an IMPACT on Brain function[2],[3].']	[('IMPORTANT_CONSIDERATION', 37), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000955', 'brain', 153, 'brain')]	0	['introduction\nvitamin  population[1]and  brain function[2],[3].']
S20-PMC3739737	PMC3739737	8/2013	S20-PMC3739737	['WHILE there is now a considerable body of research examining the IMPACT of developmental Vitamin D (dvd) deficiency on Brain outcomes, there is relatively LITTLE KNOWN about the IMPACT of Adult Vitamin D (avd) deficiency on Rodent behaviour.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 155), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 224, 'rodent')]	0	['developmental  (dvd) brain outcomes,   (avd) rodent behaviour.']
S111-PMC3739737	PMC3739737	8/2013	S111-PMC3739737	['discussion\noverall, our results clearly DEMONSTRATE that Adult Vitamin D (avd) deficiency in male sprague-dawley Rats was not associated with a gross neurochemical or behavioural phenotype.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 40)]	1	[('UBERON_0007023', 'adult organism', 57, 'adult'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 113, 'rats')]	0	['discussion\noverall, results   (avd) male sprague-dawley rats neurochemical behavioural phenotype.']
S161-PMC3739737	PMC3739737	8/2013	S161-PMC3739737	['WHILE low Vitamin D in the Adult Rodent is characterised by several behavioural and neurochemical changes in the balb/c Mouse[18], the phenotype of avd in the sprague-dawley Rat is essentially normal.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0007023', 'adult organism', 27, 'adult'), ('NCBITaxon_33208', 'Metazoa', 33, 'rodent'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 174, 'rat')]	0	['  rodent behavioural neurochemical changes balb/c mouse[18], phenotype avd sprague-dawley rat normal.']
S16-PMC3760821	PMC3760821	9/2013	S16-PMC3760821	['introduction\nit is WELL ESTABLISHED that Vitamin D plays a primary ROLE in bone health, with SEVERE Vitamin D deficiency KNOWN to cause rickets in children and osteomalacia in Adults[1].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 121)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]	0	['introduction\nit  plays bone health,  rickets children osteomalacia [1].']
S36-PMC3760821	PMC3760821	9/2013	S36-PMC3760821	['additionally, there is EMERGING EVIDENCE DEMONSTRATING an ASSOCIATION between foetal and early childhood Vitamin D deficiency and later Adult disease processes, such as multiple sclerosis, cardiovascular disease, schizophrenia, certain cancers and other Autoimmune diseases such as t1dm and lupus[16].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 136, 'adult'), ('UBERON_0001442', 'skeleton of manus', 254, 'autoimmune')]	0	['additionally, foetal childhood   disease processes, sclerosis, cardiovascular disease, schizophrenia, cancers autoimmune diseases t1dm lupus[16].']
S25-PMC3798907	PMC3798907	8/2013	S25-PMC3798907	['given the REPORTED age RELATED DIFFERENTIAL responsiveness of Vitamin E on Human Th-Cell Responses [4,8], a secondary AIM of the study was TO INVESTIGATE the in vitro EFFECTS of Vitamins E and C on Adult Peripheral Blood Mononuclear Cell (Pbmc) responses.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 167)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin E'), ('NCBITaxon_9606', 'Homo sapiens', 75, 'human'), ('CL_0000545', 'T-helper 1 cell', 81, 'Th-cell'), ('GO_0001783', 'B cell apoptotic process', 81, 'Th-cell responses'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 193, 'C'), ('PR_000004900', 'complement C3', 193, 'C'), ('UBERON_0007023', 'adult organism', 198, 'adult'), ('CL_0000111', 'peripheral neuron', 204, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 204, 'peripheral blood'), ('GO_0031097', 'medial cortex', 221, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 239, 'PBMC')]	0	['given age responsiveness  human th-cell responses [4,8], secondary  c  peripheral blood mononuclear cell (pbmc) responses.']
S68-PMC3798907	PMC3798907	8/2013	S68-PMC3798907	['Vitamin E supplementation of Adult pbmc\nwhen the EFFECTS of Vitamin E supplementation were tested on pbmc responses, UNLIKE the results for cbmc, there were no consistent trends or significant differences in Proliferation induced by the set of T-Cell stimuli (figure 2andtable 1).']	[('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('UBERON_0007023', 'adult organism', 29, 'Adult'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin E'), ('GO_0008283', 'cell proliferation', 208, 'proliferation'), ('CL_0000084', 'T cell', 244, 'T-cell')]	0	['vitamin e supplementation  pbmc\nwhen  supplementation pbmc responses, results cbmc, proliferation induced set t-cell stimuli (figure 2andtable 1).']
S122-PMC3798907	PMC3798907	8/2013	S122-PMC3798907	['ALTHOUGH the main FOCUS of our work was the supplementation of cbmc, we included a parallel study of Adult pbmc TO EXAMINE the EFFECT of the same in vitro Vitamin E supplementation on Adult Pbmc IN LIGHT OF the REPORTS of age RELATED differential responsiveness.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 127), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('UBERON_0007023', 'adult organism', 101, 'adult'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('UBERON_0007023', 'adult organism', 184, 'adult'), ('UBERON_2005026', 'primary head sinus', 190, 'PBMC')]	0	['although main supplementation cbmc,  pbmc  supplementation  pbmc age responsiveness.']
S125-PMC3798907	PMC3798907	8/2013	S125-PMC3798907	['we FOUND NO CONVINCING evidence of differential responsiveness of cbmc and Adult Pbmc to Vitamin E supplementation; HOWEVER the dose of Vitamin E used in THE current study was CONSIDERABLY LESS than that REPORTED in PREVIOUS work [4].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ANOMALY_CURIOUS_FINDING', 176), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 216)]	8	[('UBERON_0007023', 'adult organism', 75, 'adult'), ('UBERON_2005026', 'primary head sinus', 81, 'PBMC'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]	0	['responsiveness cbmc  pbmc  supplementation; dose  [4].']
S139-PMC3798907	PMC3798907	8/2013	S139-PMC3798907	['a SMALL number ( n = 40) of Adult Pbmc samples were obtained to investigate a POSSIBLE age RELATED differential responsiveness to Vitamin E. consequently the concentrations of Ascorbate and Α-Tocopherol used to supplement these pbmc cultures, was the same as that used to supplement cbmc cultures, HOWEVER these levels are lower than those FOUND in the Plasma of healthy Adults, which COULD EXPLAIN the LACK OF EFFECTS SEEN in pbmc cultures.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 340), ('INCOMPLETE_EVIDENCE', 385), ('PROBABLE_UNDERSTANDING', 391), ('INCOMPLETE_EVIDENCE', 403), ('SUPERFICIAL_RELATIONSHIP', 411), ('INCOMPLETE_EVIDENCE', 419)]	11	[('UBERON_0007023', 'adult organism', 28, 'adult'), ('UBERON_2005026', 'primary head sinus', 34, 'PBMC'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin E'), ('CHEBI_22651', 'ascorbate', 176, 'ascorbate'), ('CHEBI_27725', 'butin', 190, 'α-tocopherol'), ('UBERON_0001969', 'blood plasma', 353, 'plasma'), ('UBERON_0007023', 'adult organism', 371, 'adults')]	0	['n = 40)  pbmc samples age responsiveness . concentrations ascorbate α-tocopherol supplement pbmc cultures, supplement cbmc cultures, levels plasma healthy pbmc cultures.']
S148-PMC3798907	PMC3798907	8/2013	S148-PMC3798907	['in THE CURRENT STUDY, the EFFECTS of in vitro Vitamin E supplementation on cbmc and pbmc Effector cytokine responses did DIFFER, BUT the EFFECTS of in vitro Vitamin C supplementation were broadly SIMILAR in neonates and Adults.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('CHEBI_35224', 'effector', 89, 'effector'), ('CHEBI_33229', 'vitamin (role)', 157, 'vitamin'), ('CHEBI_18245', 'carboxylato group', 165, 'C'), ('UBERON_0007023', 'adult organism', 220, 'adults')]	0	['study,  supplementation cbmc pbmc effector cytokine responses differ, vitamin c supplementation neonates .']
S134-PMC3814422	PMC3814422	10/2013	S134-PMC3814422	['by way of analogy, in a study of Vitamin D and Adult Lung function we FOUND that, WHILST there were APPARENT ASSOCIATIONS with dietary Vitamin D intake, there was NO EVIDENCE for an association with Blood 25(Oh)D concentrations29.']	[('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 82), ('ANOMALY_CURIOUS_FINDING', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 47, 'adult'), ('UBERON_0002048', 'lung', 53, 'lung'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('UBERON_0000178', 'blood', 199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH)D')]	0	['  lung that, dietary  intake, blood 25(oh)d concentrations29.']
S8-PMC3827489	PMC3827489	10/2013	S8-PMC3827489	['DEFICIENCY of Vitamin D causes osteomalacia, leading to growth retardation and Skeletal deformities in children and osteoporosis in Adults1).']	[('IMPORTANT_CONSIDERATION', 0)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0004288', 'skeleton', 79, 'skeletal'), ('UBERON_0007023', 'adult organism', 132, 'adults1')]	0	['deficiency  causes osteomalacia, retardation skeletal deformities children osteoporosis ).']
S22-PMC3827489	PMC3827489	10/2013	S22-PMC3827489	['ALTHOUGH Vitamin D deficiency IS KNOWN to be prevalent in Adults, epidemiologic data on the prevalence of Vitamin D deficiency are LACKING in korean infants, children, and adolescents.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('FULL_UNKNOWN', 131)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adults'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]	0	['although  epidemiologic  korean infants, children, adolescents.']
S70-PMC3827489	PMC3827489	10/2013	S70-PMC3827489	['IN CONTRAST, a cochrane review REPORTED that Vitamin D supplementation in patients diagnosed with tuberculosis did not alter the rates of Sputum smear Conversion in Adults or body weight in children47).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0007311', 'sputum', 138, 'sputum'), ('GO_0006936', 'muscle contraction', 151, 'conversion'), ('UBERON_0007023', 'adult organism', 165, 'adults')]	0	['contrast, cochrane  supplementation patients diagnosed tuberculosis alter rates sputum smear conversion  children47).']
S35-PMC3888066	PMC3888066	12/2012	S35-PMC3888066	['brief survey of potential maternal sources of Vitamin A\n\nexplanation of rda for Vitamin A in foods\nthe RECOMMENDED daily allowance (rda) for Vitamin A in foods is defined as the amount needed to provide 97% or more of all groups with a sufficient quantity of Vitamin A to stay healthy.33since male Adults have the highest REQUIREMENT for Vitamin A, which is 3,000 iu, the rda is calculated to this group (table 2).']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 322)]	2	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 46, 'Vitamin A'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin A'), ('UBERON_0007023', 'adult organism', 298, 'adults'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin A')]	0	['brief survey maternal sources vitamin a\n\nexplanation rda  foods\nthe daily allowance (rda)  foods amount 97% quantity  stay healthy.33since male  3,000 iu, rda (table 2).']
S214-PMC4113768	PMC4113768	7/2014	S214-PMC4113768	['we THEREFORE AIMED TO DETERMINE WHETHER seasonal Vitamin D deficiency occurs in two healthy young Adult populations with moderate or dark skin pigmentation in cape town, WHETHER this had an EFFECT on the number and function of Circulating Blood Cells, their ability to Control to hiv-1 infection and WHETHER Vitamin D supplementation modifies the investigated responses.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 190), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 300)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adult'), ('CL_0000080', 'circulating cell', 227, 'circulating'), ('CL_0000081', 'blood cell', 239, 'blood cells'), ('UBERON_0000178', 'blood', 239, 'blood'), ('GO_0065007', 'biological regulation', 269, 'control'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]	0	['seasonal  occurs healthy young  populations dark skin pigmentation cape town, circulating blood cells, ability hiv-1 infection  supplementation modifies responses.']
S223-PMC4113768	PMC4113768	7/2014	S223-PMC4113768	['conclusions: the MAJORITY of healthy young Adults with moderate or dark skin pigmentation in cape town become Vitamin D deficient in winter.']	[('PROBABLE_UNDERSTANDING', 17)]	1	[('UBERON_0007023', 'adult organism', 43, 'adults'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]	0	['conclusions: healthy young  dark skin pigmentation cape town  winter.']
S321-PMC4113768	PMC4113768	7/2014	S321-PMC4113768	['AT PRESENT, THERE ARE NO DATA about Vitamin D (vd) supplementation, osteopenia and bone Mineral density (bmd) in Adult burn patients.']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 12)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_46662', 'mineral', 88, 'mineral'), ('UBERON_0007023', 'adult organism', 113, 'adult')]	0	['present,  (vd) supplementation, osteopenia bone mineral density (bmd)  burn patients.']
S512-PMC4113768	PMC4113768	7/2014	S512-PMC4113768	['randomised controlled trials of Vitamin D supplementation in children with asthma for PREVENTION of exacerbation and uri HAVE REPORTED positive results; such trials have not previously been conducted in Adults.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 121)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0007023', 'adult organism', 203, 'adults')]	0	['randomised  supplementation children asthma exacerbation uri positive results; .']
S631-PMC4113768	PMC4113768	7/2014	S631-PMC4113768	['; kiely, m.\nbackground: obesity is a RISK FACTOR for low circulating 25-Hydroxy Vitamin D (25(Oh)D), which is the BIOMARKER of Vitamin D status, and there are CONSISTENT negative ASSOCIATIONS between 25(Oh)D and measures of adiposity in Adults and children.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 179)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('UBERON_0007023', 'adult organism', 237, 'adults')]	0	['; kiely, m.\nbackground: obesity circulating 25-hydroxy vitamin (25(oh)d),  status, 25(oh)d adiposity  children.']
S668-PMC4113768	PMC4113768	7/2014	S668-PMC4113768	['; dyall, l.; kepa, m.\nbackground: POSSIBLE CONSEQUENCES of low Vitamin D status include osteoporosis, falls, Cardiovascular disease, cancer, and diabetes, all of which are LIKELY to be more SERIOUS for men and women of advanced age (>80 years) compared to younger Adults.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBLEM_COMPLICATION', 43), ('PROBABLE_UNDERSTANDING', 172), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('UBERON_0007023', 'adult organism', 264, 'adults')]	0	['; dyall, l.; kepa, m.\nbackground:  status osteoporosis, falls, cardiovascular disease, cancer, diabetes, men women age (>80 years) younger .']
S971-PMC4113768	PMC4113768	7/2014	S971-PMC4113768	['Genetic variants in the Vitamin D pathway that HAVE PREVIOUSLY BEEN shown to ASSOCIATE with risk of Vitamin D deficiency in healthy Adult populations were not associated with deficiency in this patient group.']	[('IMPORTANT_CONSIDERATION', 47), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult')]	0	['genetic variants   healthy  populations patient group.']
S986-PMC4113768	PMC4113768	7/2014	S986-PMC4113768	['ASSOCIATIONS between low circulating 25-Hydroxy Vitamin D (25(Oh)D), the BIOMARKER of Vitamin D status, and muscle weakness in older Adults (bischoff-ferrari, h.a., et al .']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0007023', 'adult organism', 133, 'adults')]	0	['associations circulating 25-hydroxy vitamin (25(oh)d),  status, muscle older  (bischoff-ferrari, h.a., et al .']
S1043-PMC4113768	PMC4113768	7/2014	S1043-PMC4113768	['epidemiological studies in Adults SHOWED that bone Mineral density as well as bone turnover MARKERS are ASSOCIATED with Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_46662', 'mineral', 51, 'mineral'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]	0	['epidemiological  bone mineral density bone turnover  levels.']
S1331-PMC4113768	PMC4113768	7/2014	S1331-PMC4113768	"['[""""Vitamin D supplementation in an edinburgh general practice population and ANECDOTAL evidence\\n\\nrhein, h.m.; johnson, g.\\nbackground: after we became aware of the widespread Vitamin D deficiency in our scottish general practice population in edinburgh at a latitude of 56\', our patients have received for the past few years the offer of prescriptions for Vitamin D supplements: 20,000 iu weekly for MOST Adults, 2000 iu daily for Pregnant women, 1000 iu daily for children aged 5–12, 400 iu daily for babies and children aged 0–5.""""]']"	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 396)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin D'), ('UBERON_0007023', 'adult organism', 401, 'adults'), ('GO_0007565', 'female pregnancy', 427, 'pregnant')]	0	"['[""""vitamin supplementation edinburgh population evidence\\n\\nrhein, h.m.; johnson, g.\\nbackground: became widesamin scottish population edinburgh latitude 56*, patients received prescriptionamin supplements: 20,000 iu weekly foradults, 2000 iu daily pregnant women, 1000 iu daily children aged 5–12, 400 iu daily babies children aged 0–5.""""]']"
S1544-PMC4113768	PMC4113768	7/2014	S1544-PMC4113768	['we INVESTIGATE for the FIRST TIME WHETHER Vitamin D levels MAY alter cmv serology in a cohort of non-white Adults resident in the uk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 59)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 107, 'adults')]	0	[' levels alter cmv serology non-white  resident uk.']
S1642-PMC4113768	PMC4113768	7/2014	S1642-PMC4113768	['low-dose Vitamin D supplementation is already RECOMMENDED in older Adults for PREVENTION of fractures and falls, but clinical trials investigating WHETHER higher doses COULD provide additional protection against ari are LACKING.']	[('FUTURE_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('FULL_UNKNOWN', 220)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 67, 'adults')]	0	['low-dose  supplementation older  fractures falls, higher doses ari lacking.']
S1651-PMC4113768	PMC4113768	7/2014	S1651-PMC4113768	['conclusions: addition of intermittent bolus-dose Vitamin D supplementation to a daily low-dose regimen improved Vitamin D status in older Adults and their carers, BUT it did not influence risk of ari, and was less effective at preventing uri.']	[('ANOMALY_CURIOUS_FINDING', 163)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0007023', 'adult organism', 138, 'adults')]	0	['conclusions: addition intermittent bolus-dose  supplementation daily low-dose regimen  status older  carers, ari, uri.']
S1695-PMC4113768	PMC4113768	7/2014	S1695-PMC4113768	['THIS STUDY was AIMED TO INVESTIGATE the prevalence of Vitamin D deficiency in Adult female of local population in pakistan and TO find out social and Genetic FACTORS that may CONTRIBUTE in hypovitaminosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 175)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0007023', 'adult organism', 78, 'adult'), ('SO_0000704', 'gene', 150, 'genetic')]	0	['  female local population pakistan social genetic hypovitaminosis.']
S1700-PMC4113768	PMC4113768	7/2014	S1700-PMC4113768	['results: it HAS BEEN OBSERVED that in Adult female of pakistan most of them have Vitamin D insufficiency and SOME of them were deficient while Serum calcium is not a significant BIOMARKER to check the level of Vitamin D. in obese female Vitamin D insufficiency is more than non obese.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('UBERON_0007023', 'adult organism', 38, 'adult'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]	0	['results:  female pakistan  serum calcium . obese female  obese.']
S1710-PMC4113768	PMC4113768	7/2014	S1710-PMC4113768	['we THEREFORE CONDUCTED a study TO DETERMINE the prevalence of Vitamin D deficiency in a cohort of Adults with asthma who were screened for participation in a clinical trial in london, uk, and TO IDENTIFY CORRELATES of poor asthma Control and low Vitamin D status in this population.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 204)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adults'), ('GO_0065007', 'biological regulation', 230, 'control'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]	0	['  asthma screened participation london, uk, asthma  status population.']
S2000-PMC4113768	PMC4113768	7/2014	S2000-PMC4113768	['this RAISES the HYPOTHESIS that low Vitamin D is RELATED to POOR mental health in the Adult general population.']	[('EXPLICIT_QUESTION', 5), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 60)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adult')]	0	[' mental  population.']
S2019-PMC4113768	PMC4113768	7/2014	S2019-PMC4113768	['conclusions: our results SUGGEST that low Serum 25(Oh) Vitamin D is not associated with symptoms of depression and anxiety in Adult danes from the general population.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('UBERON_0001977', 'blood serum', 42, 'serum'), ('CHEBI_30778', 'gallic acid', 48, '25(OH)'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0007023', 'adult organism', 126, 'adult')]	0	['conclusions: results serum 25(oh)  symptoms depression anxiety  danes population.']
S2045-PMC4113768	PMC4113768	7/2014	S2045-PMC4113768	['results: prevalence for Vitamin D status (25Ohd nmol/l < 30, 30–50, > 50–125, > 125) was NOTED for the following groups: preterm at 3 weeks (14%, 65%, 21%, 0%); preterm at 15 weeks on 400 iu/day (3%, 11%, 86%, 8%); Pregnant women at term (21%, 34%, 45%, 0%) with Cord Blood at term (59%, 28%, 13%, 0%); children ranging from 1–18 years (22%, 33%, 45%, 0%); osteoporosis on 400–800 iu/day (1%, 8%, 91%, 2%); and cystic fibrosis on 400–1600 iu/d (23%, 28%, 49%, 3%); healthy Adults in winter (21%, 46%, 33%, 0%); and multiple sclerosis in winter (40%, 32%, 28%, 1%).']	[('ANOMALY_CURIOUS_FINDING', 89)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 42, '25OHD'), ('GO_0007565', 'female pregnancy', 215, 'pregnant'), ('UBERON_0002240', 'spinal cord', 263, 'cord'), ('UBERON_0000178', 'blood', 268, 'blood'), ('UBERON_0007023', 'adult organism', 473, 'adults')]	0	['results:  status (25ohd nmol/l 30, 30–50, > 50–125, > 125) following groups: preterm 3 weeks (14%, 65%, 21%, 0%); preterm 15 weeks 400 iu/day (3%, 11%, 86%, 8%); pregnant women term (21%, 34%, 45%, 0%) cord blood term (59%, 28%, 13%, 0%); children 1–18 (22%, 33%, 45%, 0%); osteoporosis 400–800 iu/day (1%, 8%, 91%, 2%); cystic fibrosis 400–1600 iu/d (23%, 28%, 49%, 3%); healthy  winter (21%, 46%, 33%, 0%); sclerosis winter (40%, 32%, 28%, 1%).']
S2115-PMC4113768	PMC4113768	7/2014	S2115-PMC4113768	['2008, 62 , 1079-1089) provides representative data TO ASSESS the current Vitamin D status of Adults in germany according to latitude of residence and to identify additional DETERMINANTS of Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 173)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]	0	['2008, 62 1079-1089) representative  status  germany latitude residence  status.']
S2303-PMC4113768	PMC4113768	7/2014	S2303-PMC4113768	['in THIS cross-SECTIONAL case-CONTROL STUDY, we DESCRIBED the differences and ASSOCIATIONS in the Metabolic patterns of Adult saudis with and without hypothyroid dysfunction in RELATION to their Vitamin D status, pth, calcium and Lipid profile.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0008152', 'metabolic process', 97, 'metabolic'), ('UBERON_0007023', 'adult organism', 119, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_18059', 'lipid', 229, 'lipid')]	0	['cross-sectional case-control study, metabolic  saudis hypothyroid dysfunction  status, pth, calcium lipid profile.']
S2346-PMC4113768	PMC4113768	7/2014	S2346-PMC4113768	['in THIS INTERVENTIONAL STUDY we measured the EFFECTS of improving Vitamin D status on bone biochemical MARKERS in overweight and obese Adult saudis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adult')]	0	[' status bone biochemical overweight obese  saudis.']
S2358-PMC4113768	PMC4113768	7/2014	S2358-PMC4113768	['in THIS FOLLOW-UP STUDY we DETERMINED seasonal differences in Serum 25(Oh)D Vitamin D levels, as well as parallel changes in Metabolic parameters, in a cohort of Adult overweight and obese saudis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 27)]	4	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_71657', 'versiconol acetate', 68, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0008152', 'metabolic process', 125, 'metabolic'), ('UBERON_0007023', 'adult organism', 162, 'adult')]	0	['seasonal serum 25(oh)d  levels, changes metabolic parameters,  overweight obese saudis.']
S2469-PMC4113768	PMC4113768	7/2014	S2469-PMC4113768	['Vitamin D and tuberculosis in Adults in selected districts in the provinces baghlan, bamyan and badakhshan, afghanistan\n\nsarin, p.; manaseki-holland, s.; duffy, j.c.\nbackground: EVIDENCE for an ASSOCIATION between Vitamin D and tuberculosis (tb) is INCONSISTENT and NO previous STUDIES HAVE BEEN conducted in afghanistan.']	[('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('FULL_UNKNOWN', 266), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0007023', 'adult organism', 30, 'Adults'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]	0	['vitamin tuberculosis  selected districts provinces baghlan, bamyan badakhshan, afghanistan\n\nsarin, p.; manaseki-holland, s.; duffy, j.c.\nbackground:  tuberculosis (tb) afghanistan.']
S2674-PMC4113768	PMC4113768	7/2014	S2674-PMC4113768	['conclusions: long-term monthly Vitamin D supplementation, which increased mean 25(Oh)D concentration above 100 nmol/l for 18 months, had no EFFECT on systolic or diastolic bp in predominantly white, healthy Adults without severe Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 140)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 79, '25(OH ... D'), ('UBERON_0007023', 'adult organism', 207, 'adults'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]	0	['conclusions: long-term monthly  supplementation, 25(oh)d concentration 100 nmol/l 18 months, systolic diastolic bp white, healthy   deficiency.']
S2820-PMC4113768	PMC4113768	7/2014	S2820-PMC4113768	['methods: a total of 49 apparently healthy Adults ( n = 23 males; n = 26 female) aged 18–65 years consented to take part in the current study, conducted between february and march 2013 to remove the CONFOUNDING EFFECT of sun exposure on circulating MARKERS of Vitamin D status.']	[('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 210), ('SUPERFICIAL_RELATIONSHIP', 248)]	3	[('UBERON_0007023', 'adult organism', 42, 'adults'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]	0	['methods: 49 healthy  n = 23 males; n = 26 female) aged 18–65 consented study, february march 2013 remove sun exposure circulating  status.']
S2834-PMC4113768	PMC4113768	7/2014	S2834-PMC4113768	['conclusions: the Vitamin D ffq has now been validated for use in FUTURE STUDIES interested in assessing habitual Vitamin D intake within the general Adult population.']	[('FUTURE_WORK', 65)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0007023', 'adult organism', 149, 'adult')]	0	['conclusions:  ffq habitual  intake  population.']
S3096-PMC4113768	PMC4113768	7/2014	S3096-PMC4113768	['ALTHOUGH Vitamin D HAS BEEN ASSOCIATED with the development of tb in Adults, LITTLE RESEARCH has EXAMINED the IMPORTANCE of Vitamin D levels in children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('IMPORTANT_CONSIDERATION', 110)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 69, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]	0	['although  tb  levels children.']
S3194-PMC4113768	PMC4113768	7/2014	S3194-PMC4113768	['; pearce, s.; rasvi, s.; jagger, c.\nbackground: DESPITE RECENT concerns about the high prevalence of low Vitamin D status in much of the british Adult and pediatric population, there is a dearth of data on Vitamin D status and its PREDICTORS in very old Adults, a sub-group of the population which is at INCREASED RISK of POOR Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ANOMALY_CURIOUS_FINDING', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 304), ('IMPORTANT_CONSIDERATION', 322)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0007023', 'adult organism', 254, 'adults'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D')]	0	['; pearce, s.; rasvi, s.; jagger, c.\nbackground:  status british  pediatric population,  status old sub-group population  status.']
S217-PMC4161853	PMC4161853	8/2014	S217-PMC4161853	['moreover, Gestational Vitamin A deficiency in Animal models HAS BEEN SHOWN to reduce the Intestinal Immune Response by decreasing the number of Immune Cells in Rat offspring [119] and Controlling the size of Secondary Lymph Organ and the efficiency of Immune Responses in the Adult Mouse offspring [120].']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 46, 'animal'), ('UBERON_0000160', 'intestine', 89, 'intestinal'), ('GO_0006955', 'immune response', 100, 'immune response'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('CL_0000738', 'leukocyte', 144, 'immune cells'), ('UBERON_0002405', 'immune system', 144, 'immune'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 160, 'rat'), ('GO_0065007', 'biological regulation', 184, 'controlling'), ('UBERON_0005174', 'dorsal region element', 208, 'secondary lymph organ'), ('GO_0006955', 'immune response', 252, 'immune responses'), ('UBERON_0002405', 'immune system', 252, 'immune'), ('UBERON_0007023', 'adult organism', 276, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 282, 'mouse')]	0	['moreover, gestational  animal intestinal immune response decreasing immune cells rat offspring [119] controlling secondary lymph organ efficiency immune responses  mouse offspring [120].']
S212-PMC4169453	PMC4169453	9/2014	S212-PMC4169453	['ANOTHER INTERESTING OBSERVATION RELATES to pth as a functional MARKER of Vitamin D status in Adults, children and infants but not necessarily in neonates[44]–[47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults')]	0	['another pth functional  status children infants neonates[44]–[47].']
S135-PMC4171568	PMC4171568	9/2014	S135-PMC4171568	['Vitamin D as a risk factor for the development of schizophrenia\nit HAS BEEN HYPOTHESIZED that low Prenatal Vitamin D is a risk factor for the incidence of Adult-onset schizophrenia AS the lack of this fat-soluble Vitamin and Steroid Hormone MAY DETRIMENTALLY IMPACT on the developing foetal Brain [102].']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 181), ('INCOMPLETE_EVIDENCE', 241), ('IMPORTANT_CONSIDERATION', 245), ('SUPERFICIAL_RELATIONSHIP', 259)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_33229', 'vitamin (role)', 213, 'vitamin'), ('CHEBI_26764', 'steroid hormone', 225, 'steroid hormone'), ('UBERON_0000955', 'brain', 291, 'brain')]	0	['vitamin schizophrenia\nit prenatal  -onset schizophrenia fat-soluble vitamin steroid hormone foetal brain [102].']
S14-PMC4256222	PMC4256222	12/2014	S14-PMC4256222	['introduction\nAdult bone mass MAY BE INFLUENCED by FACTORS operating as early as in fetal Life[1], and there has in particular been interest on the ROLE of maternal Vitamin D status in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0007023', 'adult organism', 13, 'Adult'), ('UBERON_0000104', 'life cycle', 89, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]	0	['introduction\n bone mass fetal life[1], maternal  status pregnancy.']
S185-PMC4277121	PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]	0	['antioxidants\noxidative mitochondrial dysfunction hallmarks ds tissues neurological phenotypes ds lifespan.1,91cortical neurons ds fetal brains elevated levels reactive oxygen species, survival treatment antioxidants.92several hsa21 genes, among sod1 bach1 ets2 s100b oxidative overexpressed.9consistent observations, levels oxidative elevated brains  ts65dn, male ts65dn mice fed diet  (0.4 g kg) age 4 months ~8 months 10 months, levels oxidative decreased.93performance wram 8 months, 10 months; loss trka receptor bfcn prevented.']
S257-PMC4277121	PMC4277121	12/2015	S257-PMC4277121	['for two Drugs, Fluoxetine and sag 1.1, treatment solely in the early Postnatal time periods resulted in successful l/m at young Adult ages of 6 weeks and 16 weeks, respectively.53,77indeed, for rescue on the mwm (but not on the spontaneous alternation y-maze), sag 1.1 treatment involved only a single p0 injection.77three Drugs were tested by the treatment of only Pregnant dams: Fluoxetine and Nap/sal were injected during Gestation;59,98and Choline was provided in Food to dams during Gestation and through weaning.105in another treatment, Vitamin E was provided in Food both to dams during Gestation and to the offspring through to the age of l/m testing.94in each case, the Prenatal Drug exposure resulted in AT LEAST the partial rescue of l/m in Adult offspring.']	[('PROBABLE_UNDERSTANDING', 714)]	1	[('CHEBI_23888', 'drug', 8, 'drugs'), ('CHEBI_5131', 'flurochloridone', 15, 'fluoxetine'), ('GO_0007567', 'parturition', 69, 'postnatal'), ('UBERON_0007023', 'adult organism', 128, 'adult'), ('CHEBI_23888', 'drug', 323, 'drugs'), ('GO_0007565', 'female pregnancy', 366, 'pregnant'), ('CHEBI_5131', 'flurochloridone', 381, 'fluoxetine'), ('CHEBI_13389', 'NAD', 396, 'NAP'), ('GO_0007565', 'female pregnancy', 425, 'gestation'), ('CHEBI_15354', 'choline', 444, 'choline'), ('CHEBI_33290', 'food', 468, 'food'), ('GO_0007565', 'female pregnancy', 488, 'gestation'), ('CHEBI_27300', 'vitamin D', 543, 'vitamin E'), ('CHEBI_33290', 'food', 569, 'food'), ('GO_0007565', 'female pregnancy', 594, 'gestation'), ('GO_0007565', 'female pregnancy', 679, 'prenatal'), ('CHEBI_23888', 'drug', 688, 'drug'), ('UBERON_0007023', 'adult organism', 752, 'adult')]	0	['drugs, fluoxetine sag 1.1, treatment postnatal periods resulted l/m young  ages 6 weeks 16 weeks, respectively.53,77indeed, rescue mwm (but spontaneous alternation y-maze), sag 1.1 treatment single p0 injection.77three drugs treatment pregnant dams: fluoxetine nap/sal injected gestation;59,98and choline food dams gestation weaning.105in treatment,  food dams gestation offspring age l/m testing.94in case, prenatal drug exposure resulted rescue l/m  offspring.']
S28-PMC4329404	PMC4329404	10/2014	S28-PMC4329404	['MULTIPLE STUDIES HAVE REPORTED a positive CORRELATION between Serum Vitamin D and Foxp3+Regulatory T-Cell numbers in both the periphery and Airways of Adults (24) and children (25,26).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000017653', 'zinc finger protein ZFPM2', 82, 'FoxP3'), ('CL_0000815', 'regulatory T cell', 88, 'regulatory T-cell'), ('GO_0065007', 'biological regulation', 88, 'regulatory'), ('GO_0005854', 'nascent polypeptide-associated complex', 100, '-'), ('UBERON_0001005', 'respiratory airway', 140, 'airways'), ('UBERON_0007023', 'adult organism', 151, 'adults')]	0	['multiple positive serum  foxp3+regulatory t-cell periphery airways  (24) children (25,26).']
S133-PMC4329404	PMC4329404	10/2014	S133-PMC4329404	['discussion\nwe HAVE SHOWN that Adult female Mice given a Vitamin D-deficient diet for 4\xa0weeks (from day-16 Gestation until 3\xa0weeks Postpartum) developed a th2-skewed Pulmonary Immune phenotype, concomitant with reduced Cd4+Il-10+Regulatory Cells.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('UBERON_0007023', 'adult organism', 30, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 43, 'mice'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('GO_0007565', 'female pregnancy', 130, 'postpartum'), ('UBERON_0002048', 'lung', 165, 'pulmonary'), ('UBERON_0002405', 'immune system', 175, 'immune'), ('PR_000001204', 'C-C chemokine receptor type 8', 218, 'CD4'), ('PR_000001470', 'interleukin-28B', 222, 'IL-10'), ('CL_0000232', 'erythrocyte', 228, 'regulatory cells'), ('GO_0065007', 'biological regulation', 228, 'regulatory')]	0	['discussion\nwe  female mice 4\xa0weeks (from day-16 gestation 3\xa0weeks postpartum) th2-skewed pulmonary immune phenotype, cd4+il-10+regulatory cells.']
S137-PMC4329404	PMC4329404	10/2014	S137-PMC4329404	['dietary Vitamin D deficiency in an Adult MODEL of ovalbumin-induced aad DEMONSTRATED worse ahr, Eosinophilia and reduced Il-10 levels (31).']	[('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 72)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 35, 'adult'), ('CL_0000771', 'eosinophil', 96, 'eosinophilia'), ('PR_000001470', 'interleukin-28B', 121, 'IL-10')]	0	['dietary   ovalbumin-induced aad ahr, eosinophilia il-10 levels (31).']
S141-PMC4329404	PMC4329404	10/2014	S141-PMC4329404	['a PREVIOUS STUDY has investigated the EFFECT of in utero and early-Life Vitamin D deficiency on aad, BUT Allergen challenge was commenced in Adult Mice, rather than during the Neonatal Period (32).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101)]	3	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_50904', 'allergen', 105, 'allergen'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('UBERON_0007221', 'neonate stage', 176, 'neonatal period')]	0	['utero early-life  aad, allergen commenced  mice, neonatal period (32).']
S147-PMC4329404	PMC4329404	10/2014	S147-PMC4329404	['this highlights the IMPORTANCE of age and Vitamin D status on Lung function in Adults COMPARED TO in utero and early-Life deficiency.']	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 62, 'lung'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0000104', 'life cycle', 117, 'life')]	0	['age  status lung  utero early-life deficiency.']
S148-PMC4329404	PMC4329404	10/2014	S148-PMC4329404	['it is CONSISTENT with FINDINGS from epidemiological studies which have FAILED TO SHOW reliable EFFECTS of Vitamin D deficiency or insufficiency on Lung function in children with asthma (6–8,11) ALTHOUGH ASSOCIATIONS are REPORTED in Adults (33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('DIFFICULT_TASK', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 220)]	10	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0002048', 'lung', 147, 'lung'), ('UBERON_0007023', 'adult organism', 232, 'adults')]	0	['epidemiological  lung children asthma (6–8,11)  (33).']
S151-PMC4329404	PMC4329404	10/2014	S151-PMC4329404	['data from Adult studies SHOW an ASSOCIATION between Vitamin D status and Steroid response (23).']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('UBERON_0007023', 'adult organism', 10, 'adult'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_35341', 'steroid', 73, 'steroid')]	0	['data   status steroid response (23).']
S160-PMC4329404	PMC4329404	10/2014	S160-PMC4329404	['the same EFFECT was seen in a PREVIOUS STUDY that has investigated the EFFECTS of Vitamin D supplementation on allergic Airways disease in an ovalbumin MODEL using Adult Mice.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 120, 'airways'), ('UBERON_0007023', 'adult organism', 164, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'mice')]	0	[' supplementation allergic airways disease ovalbumin using  mice.']
S168-PMC4329404	PMC4329404	10/2014	S168-PMC4329404	['a reduction in Airway Remodelling HAS BEEN SHOWN in Adult ovalbumin-induced aad with additional Vitamin D therapy (36).']	[('INCOMPLETE_EVIDENCE', 34)]	1	[('GO_0003313', 'heart rudiment development', 15, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 15, 'airway'), ('UBERON_0007023', 'adult organism', 52, 'adult'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]	0	['reduction airway remodelling  ovalbumin-induced aad  therapy (36).']
S173-PMC4329404	PMC4329404	10/2014	S173-PMC4329404	['a pilot STUDY of high-dose Vitamin D supplementation in Adults ( n \xa0=\xa04) HAS SHOWN an increase in circulating Il-10-producing Peripheral Blood Mononuclear Cells (Pbmcs) (37); HOWEVER, these were otherwise healthy subjects and only Circulating Cells were assessed.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0007023', 'adult organism', 56, 'adults'), ('PR_000001470', 'interleukin-28B', 110, 'IL-10'), ('UBERON_0012101', 'perinatal stage', 126, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 143, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 143, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 162, 'PBMCs'), ('CL_0000080', 'circulating cell', 231, 'circulating cells')]	0	['high-dose  supplementation  n \xa0=\xa04) increase circulating il-10-producing peripheral blood mononuclear cells (pbmcs) (37); however, healthy subjects circulating cells assessed.']
S178-PMC4329404	PMC4329404	10/2014	S178-PMC4329404	['in addition, an Adult Murine MODEL of Vitamin D supplementation in ovalbumin-induced allergic Airways disease DEMONSTRATED an increase in Circulating T Regulatory Cells after Vitamin D supplementation, but levels of Pulmonary Tregs were NOT REPORTED (31).']	[('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 237)]	3	[('UBERON_0007023', 'adult organism', 16, 'adult'), ('NCBITaxon_39107', 'Murinae', 22, 'murine'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 94, 'airways'), ('CL_0000080', 'circulating cell', 138, 'circulating'), ('CL_0000902', 'induced T-regulatory cell', 150, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 152, 'regulatory'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0002048', 'lung', 216, 'pulmonary'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 226, 'Tregs')]	0	['addition,   supplementation ovalbumin-induced allergic airways disease increase circulating cells  supplementation, levels pulmonary tregs (31).']
S180-PMC4329404	PMC4329404	10/2014	S180-PMC4329404	['it MAY BE that ONLY alterations in circulating T Regulatory Cells are apparent following supplementation with Vitamin D.\nwe have PREVIOUSLY SHOWN that transfer of T Regulatory Cells prevented Development Of Airway Remodelling in an Adult Mouse MODEL of aad (40).']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CL_0000902', 'induced T-regulatory cell', 47, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 49, 'regulatory'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 163, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 165, 'regulatory'), ('GO_0032498', 'detection of muramyl dipeptide', 192, 'development of airway remodelling'), ('UBERON_0001005', 'respiratory airway', 207, 'airway'), ('UBERON_0007023', 'adult organism', 232, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 238, 'mouse')]	0	['alterations circulating cells following supplementation .\nwe transfer cells airway remodelling  mouse aad (40).']
S70-PMC4329745	PMC4329745	10/2014	S70-PMC4329745	['as well, the RELATIONSHIP between schizophrenia in Adult men and Vitamin D supply during the first year of Life was SHOWN in a study conducted by mcgrath et al.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 116)]	2	[('UBERON_0007023', 'adult organism', 51, 'adult'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000104', 'life cycle', 107, 'life')]	0	['well, schizophrenia  men  supply year life mcgrath et al.']
S93-PMC4340999	PMC4340999	3/2015	S93-PMC4340999	['INCONSISTENT findings and MIXED explanations of underlying mechanism HAVE BEEN REPORTED, including SPECULATION that early temperature exposure is ASSOCIATED with physiological Regulation Of Birth Weight or that extremely low ambient temperature INFLUENCES the Conceived Embryo or the selection of the Sperm that fuses with the Ovum.19–21HOWEVER, the findings from the current study APPEARED to more strongly SUGGEST the POSSIBLE etiological ROLE of Prenatal maternal exposure to ultraviolet b radiation (uvb) and Vitamin D status in Adult chronic diseases.29–31\nsun exposure provides one of the MAJOR ways to meet Vitamin D REQUIREMENTS during Pregnancy, ESPECIALLY for those of older generations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 334), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 335), ('ANOMALY_CURIOUS_FINDING', 382), ('INCOMPLETE_EVIDENCE', 408), ('INCOMPLETE_EVIDENCE', 420), ('SUPERFICIAL_RELATIONSHIP', 441), ('IMPORTANT_CONSIDERATION', 595), ('IMPORTANT_CONSIDERATION', 624), ('IMPORTANT_CONSIDERATION', 655)]	16	[('GO_0009937', 'regulation of gibberellic acid mediated signaling pathway', 176, 'regulation of birth weight'), ('GO_0070268', 'cornification', 260, 'conceived'), ('UBERON_0000922', 'embryo', 270, 'embryo'), ('CL_0000019', 'sperm', 301, 'sperm'), ('UBERON_0000978', 'leg', 327, 'ovum'), ('GO_0007565', 'female pregnancy', 449, 'prenatal'), ('CHEBI_27300', 'vitamin D', 513, 'vitamin D'), ('UBERON_0007023', 'adult organism', 533, 'adult'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('GO_0007565', 'female pregnancy', 644, 'pregnancy')]	0	['inconsistent reported, temperature exposure physiological birth ambient temperature conceived embryo selection sperm fuses ovum.19–21however, etiological prenatal maternal exposure ultraviolet b radiation (uvb)  status  chronic diseases.29–31\nsun exposure meet  pregnancy, older generations.']
S95-PMC4340999	PMC4340999	3/2015	S95-PMC4340999	['low Vitamin D during the second or third Trimester of Pregnancy HAS BEEN SUGGESTED to be ASSOCIATED with Adult obesity.31,33in THE CURRENT STUDY, spring and early summer peaks and winter troughs for bmi and wc were evident.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 127)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 41, 'trimester'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('UBERON_0007023', 'adult organism', 105, 'adult')]	0	['low  third trimester pregnancy  obesity.31,33in study, spring summer peaks winter troughs bmi wc evident.']
S99-PMC4340999	PMC4340999	3/2015	S99-PMC4340999	['FURTHER STUDIES ARE WARRANTED to test the ASSOCIATION between Prenatal Vitamin D status and Adult adiposity in an Adult population older than 35 years.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adult'), ('UBERON_0007023', 'adult organism', 114, 'adult')]	0	['prenatal  status  adiposity  population older 35 years.']
S102-PMC4340999	PMC4340999	3/2015	S102-PMC4340999	['ll in the PRESENT STUDY followed an opposite seasonal TREND to that of Adult adiposity measures, for which maternal uvb exposure (and HENCE Vitamin D status) is STILL a reasonable EXPLANATION.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 134), ('IMPORTANT_CONSIDERATION', 161), ('PROBABLE_UNDERSTANDING', 180)]	5	[('UBERON_0007023', 'adult organism', 71, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]	0	['followed seasonal  adiposity measures, maternal uvb exposure (and  status) explanation.']
S106-PMC4340999	PMC4340999	3/2015	S106-PMC4340999	['lucas et al FOUND that seasonal variation in Vitamin D status in australian Adults (living in an area spanning 27°–43° south) had greater amplitude compared to australian Adults living in a different region, and Vitamin D deficiency increased with increasing latitude, REFLECTING stronger seasonal variation in ambient uvb and less skin exposure due to colder temperatures.38hunan, being another site presenting seasonal variation in ll, has lower latitude than seven other study sites but the greatest yearly sunshine variation of all the study sites (seeetable 1).']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 269)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0007023', 'adult organism', 76, 'adults'), ('UBERON_0007023', 'adult organism', 171, 'adults'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]	0	['lucas et al seasonal  status australian  (living spanning 27°–43° south) amplitude australian  living region,  latitude, seasonal ambient uvb skin exposure colder temperatures.38hunan, site presenting seasonal ll, latitude seven sites yearly sunshine sites (seeetable 1).']
S109-PMC4340999	PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]	0	['results prenatal  status  obesity39,40and chronic diseases.8–10however, seasonal region anthropometric prenatal  status geographic regions.']
S112-PMC4340999	PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]	0	['although mob  ll, adiposity, central adiposity, prenatal exposure  late third trimesters adiposity life.']
S76-PMC4377870	PMC4377870	3/2015	S76-PMC4377870	['antioxidants including Lycopene APPEAR to have positive INFLUENCES in Respiratory conditions, further detail is provided below on EVIDENCE for Vitamin C, Vitamin E and Flavonoids and their ROLE in the maternal diet, diets of children and Adults with asthma and Adults with copd.']	[('ANOMALY_CURIOUS_FINDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 189)]	4	[('CHEBI_15948', 'lycopene', 23, 'lycopene'), ('UBERON_0001004', 'respiratory system', 70, 'respiratory'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('CHEBI_72544', 'flavonoids', 168, 'flavonoids'), ('UBERON_0007023', 'adult organism', 238, 'adults'), ('UBERON_0007023', 'adult organism', 261, 'adults')]	0	['antioxidants lycopene positive respiratory conditions, detail  flavonoids maternal diet, diets children  asthma  copd.']
S87-PMC4377870	PMC4377870	3/2015	S87-PMC4377870	['[22] also reported CONFLICTING EVIDENCE for EFFECTS of Vitamin C intake in Adults, with epidemiological STUDIES SHOWING a positive ASSOCIATION between Vitamin C intake and Lung function in SOME [65], but NOT ALL studies [23,66].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 189), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204)]	9	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('UBERON_0007023', 'adult organism', 75, 'adults'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin C'), ('UBERON_0002048', 'lung', 172, 'lung')]	0	['[22]  intake epidemiological positive  intake lung [65], [23,66].']
S93-PMC4377870	PMC4377870	3/2015	S93-PMC4377870	['indeed an epidemiological study in the united kingdom of over 7000 Adults aged 45–74 years FOUND that increased Plasma Vitamin C concentration was ASSOCIATED with a decreased risk of obstructive Airways disease, SUGGESTIVE of a PROTECTIVE EFFECT [69].']	[('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('UBERON_0007023', 'adult organism', 67, 'adults'), ('UBERON_0001969', 'blood plasma', 112, 'plasma'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin C'), ('UBERON_0001005', 'respiratory airway', 195, 'airways')]	0	['indeed epidemiological united kingdom 7000  aged 45–74 plasma  concentration decreased obstructive airways disease, [69].']
S154-PMC4377870	PMC4377870	3/2015	S154-PMC4377870	['ONLY ONE intervention TRIAL HAS BEEN conducted using Vitamin D in Adults with asthma, which FOUND that rate of first exacerbation was reduced in subjects who demonstrated an increase in circulating Vitamin D3 following supplementation [122].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 92)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0007023', 'adult organism', 66, 'adults'), ('CHEBI_33279', 'vitamin D5', 198, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 198, 'vitamin D3')]	0	['using   asthma, rate exacerbation subjects increase circulating vitamin d3 following supplementation [122].']
S52-PMC4380518	PMC4380518	9/2014	S52-PMC4380518	['shea et al studied 2500 elderly Adults and FOUND that lack of pnv use was ASSOCIATED with higher odds of Vitamin D insufficiency (<75 nmol/l) in both black (5.2 (95% ci: 3.5, 7.7)) and white participants (or 2.6, 95% ci: 2.0, 3.2), HOWEVER these subjects were much older and not Pregnant.26a SMALL turkish STUDY of 79 Pregnant women SHOWED significantly higher 25(Oh)D levels among women reporting pnv use in the third trimester,27BUT this study DID NOT include women of african descent and DID NOT have the power to address POTENTIAL INTERACTION by bmi.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 333), ('PROBLEM_COMPLICATION', 431), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 491), ('INCOMPLETE_EVIDENCE', 525), ('SUPERFICIAL_RELATIONSHIP', 535)]	10	[('UBERON_0007023', 'adult organism', 32, 'adults'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 279, 'pregnant'), ('GO_0007565', 'female pregnancy', 318, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 361, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 361, '25(OH)D')]	0	['shea et al 2500 elderly  pnv higher  (<75 nmol/l) black (5.2 (95% ci: 3.5, 7.7)) white participants (or 2.6, 95% ci: 2.0, 3.2), subjects older pregnant.26a turkish 79 pregnant women higher 25(oh)d levels among women pnv third trimester,27but women african descent bmi.']
S187-PMC4383575	PMC4383575	1/2015	S187-PMC4383575	['maternal Intake of fruits rich in Vitamin C was ASSOCIATED with lower adduct levels in Cord Blood, which is IN LINE WITH PREVIOUS FINDINGS; inverse ASSOCIATIONS with vitamin c HAVE BEEN REPORTED in Adults (palli et al.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 176)]	5	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin C'), ('UBERON_0002240', 'spinal cord', 87, 'cord'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0007023', 'adult organism', 198, 'adults')]	0	['maternal intake fruits rich  adduct levels cord blood, findings; vitamin c  (palli et al.']
S20-PMC4396835	PMC4396835	1/2015	S20-PMC4396835	['stumpf and privette [16] first SUGGESTED that Vitamin D deficiency in Adults MIGHT CONTRIBUTE to the pathogenesis of certain psychiatric disorders, including depression.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 83)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0007023', 'adult organism', 70, 'adults')]	0	['stumpf privette [16]   pathogenesis psychiatric disorders, depression.']
S134-PMC4396835	PMC4396835	1/2015	S134-PMC4396835	['OUR FINDINGS of lower Vitamin D levels in children with asd, COMPARED TO their siblings, also ACCORD WITH results from a population-based study from the faroe islands, in the north atlantic ocean, of Vitamin D levels in adolescents and young Adults with asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 242, 'adults')]	0	[' levels children asd, siblings, accord results population-based faroe islands, north atlantic ocean,  levels adolescents young  asd.']
S169-PMC4396835	PMC4396835	1/2015	S169-PMC4396835	['three DIFFERENT independent findings POINT towards a ROLE for Vitamin D in the development of asd: (1) increased risk for asd in offspring of migrants, especially from countries with a dark-skinned population and from cultures where women use covered clothing; (2) low 25(Oh)D levels in groups of newborn children, who later have developed asd, and in groups of children and Adults with asd; and (3) an ASSOCIATION between season of Birth and asd, in OUR STUDY not extending to the high-risk groups of migrants, SUGGESTING that these groups are exposed to suboptimal Vitamin D levels the whole year.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 403), ('QUESTION_ANSWERED_BY_THIS_WORK', 451), ('INCOMPLETE_EVIDENCE', 512)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 269, '25(OH)D'), ('UBERON_0007023', 'adult organism', 375, 'adults'), ('GO_0007567', 'parturition', 433, 'birth'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]	0	['three  asd: (1) asd offspring migrants, countries dark-skinned population cultures women covered clothing; (2) 25(oh)d levels newborn children, asd, children  asd; (3) season birth asd, migrants, exposed  levels whole year.']
S121-PMC4405493	PMC4405493	4/2015	S121-PMC4405493	['UNFORTUNATELY, the increasing use of multivitamins and Mineral dietary supplements in younger to older Adults DOES NOT APPEAR TO BE ASSOCIATED with a corresponding increase in Serum 25-oh Vitamin D concentrations [3,19,41].']	[('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 110), ('ANOMALY_CURIOUS_FINDING', 119), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_46662', 'mineral', 55, 'mineral'), ('UBERON_0007023', 'adult organism', 103, 'adults'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]	0	['unfortunately, multivitamins mineral dietary supplements younger older  increase serum 25-oh  concentrations [3,19,41].']
S24-PMC4417995	PMC4417995	4/2015	S24-PMC4417995	['data in Adults SUGGESTS that Vitamin D levels less than approximately 30\u2009ng/ml are ASSOCIATED with changes in Parathyroid hormone levels, as well as Intestinal calcium transport [13].']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('UBERON_0007023', 'adult organism', 8, 'adults'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 110, 'parathyroid'), ('UBERON_0000160', 'intestine', 149, 'intestinal')]	0	['data   levels 30\u2009ng/ml changes parathyroid hormone levels, intestinal calcium transport [13].']
S537-PMC4448820	PMC4448820	5/2015	S537-PMC4448820	['caption (table-wrap): table 6\n\neffects of Micronutrient supplementation on Immune function and vaccine responses (Human studies)1type of malnutrition and type of Immune functioneffects of supplementation on Immune System (reference)vitamin a\u2003Epithelial barrier function● high-dose vas above 6 mo of age decreases risk of death from infections such as measles and diarrheal diseases (290)● vas in the context of hiv infection or Lower Respiratory Tract infections HAS BEEN ASSOCIATED with adverse outcomes (105,263,290–292)● improved barrier function (105)● abnormal dual-Sugar (Lactulose, Mannitol) Intestinal permeability inversely CORRELATED with Serum Retinol (293) and PARTIALLY normalized by supplementation in va-deficient Individuals in SOME STUDIES (294) BUT NOT OTHERS (295,296)● increased symptomatology after high-dose vas during acute Lower Respiratory Tract infections REPORTED in SOME STUDIES (105) MAY INDICATE restored Mucus Production\u2003innate physiologic barriers● vas did not affect crp, saa, and/or agp concentrations among children with subclinical or clinical vad (297–299)● crp and agp did not change in men with low va stores given va (300)\u2003Macrophage function● increased Monocyte numbers (301)● decreased Tnf-Α concentrations in children (301) BUT the OPPOSITE in men (106)● decreased Ifn-Γ concentrations in children (302) but not in Pregnant women (303)● increased Il-10 concentrations in children (105,301) BUT no or an opposite effect in Adults (106,303,304)\u2003Neutrophil function● Neutrophil Phagocytosis of latex beads increased in va-deficient children given a single dose of Va (305)● Neutrophil Phagocytosis of E. Coli did not change in men with low Va stores given Va (300)\u2003Nk Cell function● an increase in Nk Cells in hiv-infected children supplemented with Va (105)● Nk Cell numbers did not change in men with low Va given supplemental Va; HOWEVER, there was a positive CORRELATION between Va stores and Peripheral Blood Nk Cells (300)\u2003T Cell function● increased Lymphocyte counts, particularly cd4 counts (105)● Cd4:Cd8 ratios were increased or unchanged by supplementation (306)● increase in Naive cd4 T Cells after supplementation; higher Memory Cd8, Cd45Ro (307)● higher Mitogen-induced Il-2, Il-4, and Tnf in response to supplementation (106)\u2003B Cell function● supplementation had no overall effect on Measles vaccine response (308) and a negative response in Individuals with baseline high titers (103)● no overall effect on oral polio vaccination● supplemented children increased Igg1 responses to dtp, minor igg3 response, no change in igg2 and igg4 (309)● no overall effect on bcg vaccine in Va-supplemented children, lower response in va-supplemented boys at 2 mo (310)● increased Antibody responses to some vaccines (Measles vaccine by 9 mo of age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response to ppd in boys (103) and hospitalized children (105)Zinc\u2003Epithelial barrier function● zn supplementation in children LED TO an improvement in the lactulose:Mannitol Excretion ratio in SOME (311) BUT NOT OTHER (312,313) STUDIES; ratio MAY improve in infected children without zn deficiency given supplemental zn (314)\u2003innate physiologic barriers ● zn-supplemented children had higher Serum Complement C3 (315)\u2003Nk Cell function● children with diarrhea supplemented with zn supplementation do not exhibit an increase in Nk Cells (316)● increased Nk Cell activity in the elderly (317)\u2003T Cell function● increased cd4+ cell count in aids patients (318)● increased Thymocyte count in Thymus (319)● increased thymulin activity (320)● no CONSISTENT effect of zn supplementation on dth to tb Antigen [reviewed in (103)]\u2003B Cell function● no effect of zn supplementation of mothers on Bcg response in children (321)\nagp, α1-acid Glycoprotein; bcg, bacille calmette-guérin; cd, cluster of differentiation; Cd45Ro , Cluster Of Differentiation Antigen 45 Ro; Crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, Serum Amyloid a; tb, tuberculosis; va, Vitamin A; vad, Vitamin A deficiency; vas, Vitamin A supplementation.']	[('INCOMPLETE_EVIDENCE', 463), ('SUPERFICIAL_RELATIONSHIP', 472), ('SUPERFICIAL_RELATIONSHIP', 633), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 763), ('INCOMPLETE_EVIDENCE', 882), ('INCOMPLETE_EVIDENCE', 894), ('INCOMPLETE_EVIDENCE', 913), ('INCOMPLETE_EVIDENCE', 917), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1267), ('ANOMALY_CURIOUS_FINDING', 1267), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1433), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1873), ('SUPERFICIAL_RELATIONSHIP', 1903), ('SUPERFICIAL_RELATIONSHIP', 3021), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3088), ('INCOMPLETE_EVIDENCE', 3088), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3099), ('INCOMPLETE_EVIDENCE', 3123), ('INCOMPLETE_EVIDENCE', 3138), ('INCOMPLETE_EVIDENCE', 3633)]	23	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 42, 'micronutrient'), ('UBERON_0002405', 'immune system', 75, 'immune'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('UBERON_0002405', 'immune system', 162, 'immune'), ('UBERON_0002405', 'immune system', 207, 'immune system'), ('UBERON_0000483', 'epithelium', 242, 'Epithelial'), ('UBERON_0004905', 'articulation', 428, 'lower respiratory tract'), ('CHEBI_24870', 'ion', 571, 'sugar'), ('CHEBI_25098', 'lyxoside', 578, 'lactulose'), ('CHEBI_25169', 'mannoside', 589, 'mannitol'), ('UBERON_0000160', 'intestine', 599, 'intestinal'), ('UBERON_0001977', 'blood serum', 649, 'serum'), ('CHEBI_26536', 'retinoic acid', 655, 'retinol'), ('NCBITaxon_1', 'root', 729, 'individuals'), ('UBERON_0004905', 'articulation', 847, 'lower respiratory tract'), ('GO_0007498', 'mesoderm development', 935, 'mucus production'), ('UBERON_0000912', 'mucus', 935, 'mucus'), ('CL_0000235', 'macrophage', 1163, 'Macrophage'), ('CL_0000576', 'monocyte', 1194, 'monocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 1228, 'TNF-α'), ('PR_000008920', 'interferon alpha-7', 1308, 'IFN-γ'), ('GO_0007565', 'female pregnancy', 1358, 'pregnant'), ('PR_000001470', 'interleukin-28B', 1390, 'IL-10'), ('UBERON_0007023', 'adult organism', 1465, 'adults'), ('CL_0000775', 'neutrophil', 1486, 'Neutrophil'), ('CL_0000775', 'neutrophil', 1507, 'Neutrophil'), ('GO_0007608', 'sensory perception of smell', 1507, 'Neutrophil'), ('GO_0006909', 'phagocytosis', 1518, 'phagocytosis'), ('CHEBI_37958', 'dye', 1604, 'VA'), ('CL_0000775', 'neutrophil', 1614, 'Neutrophil'), ('GO_0070231', 'T cell apoptotic process', 1614, 'Neutrophil phagocytosis'), ('NCBITaxon_10088', 'Mus <genus>', 1641, 'E. coli'), ('CHEBI_37958', 'dye', 1680, 'VA'), ('CHEBI_37958', 'dye', 1696, 'VA'), ('CL_0000623', 'natural killer cell', 1705, 'NK cell'), ('GO_0005634', 'nucleus', 1705, 'NK'), ('CL_0000623', 'natural killer cell', 1738, 'NK cells'), ('GO_0005634', 'nucleus', 1738, 'NK'), ('CHEBI_37958', 'dye', 1790, 'VA'), ('CL_0000623', 'natural killer cell', 1800, 'NK cell'), ('GO_0005634', 'nucleus', 1800, 'NK'), ('CHEBI_37958', 'dye', 1847, 'VA'), ('CHEBI_37958', 'dye', 1869, 'VA'), ('CHEBI_37958', 'dye', 1923, 'VA'), ('UBERON_0012101', 'perinatal stage', 1937, 'peripheral blood'), ('CL_0000623', 'natural killer cell', 1954, 'NK cells'), ('GO_0005634', 'nucleus', 1954, 'NK'), ('CL_0000084', 'T cell', 1969, 'T cell'), ('CL_0000542', 'lymphocyte', 1996, 'lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 2046, 'CD4'), ('PR_000005170', 'CD37 molecule', 2050, 'CD8'), ('CL_0000898', 'naive T cell', 2127, 'naive ... T cells'), ('GO_0007613', 'memory', 2175, 'memory'), ('PR_000005170', 'CD37 molecule', 2182, 'CD8'), ('PR_000005170', 'CD37 molecule', 2187, 'CD45RO'), ('CHEBI_52290', 'mitogen', 2208, 'mitogen'), ('PR_000001470', 'interleukin-28B', 2224, 'IL-2'), ('PR_000001470', 'interleukin-28B', 2230, 'IL-4'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 2240, 'TNF'), ('CL_0000236', 'B cell', 2281, 'B cell'), ('NCBITaxon_33208', 'Metazoa', 2339, 'measles'), ('NCBITaxon_1', 'root', 2397, 'individuals'), ('GO_0071735', 'IgG immunoglobulin complex', 2519, 'IgG1'), ('CHEBI_37958', 'dye', 2633, 'VA'), ('GO_0042571', 'immunoglobulin complex, circulating', 2723, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 2760, 'measles'), ('CHEBI_27377', 'Unsym-bis(4*-chlorophenyl)ethylene', 2956, 'Zinc'), ('UBERON_0000483', 'epithelium', 2961, 'Epithelial'), ('CHEBI_25169', 'mannoside', 3060, 'mannitol'), ('GO_0007588', 'excretion', 3069, 'excretion'), ('UBERON_0001977', 'blood serum', 3287, 'serum'), ('PR_000004908', 'complement component C8 alpha chain', 3293, 'complement C3'), ('CL_0000623', 'natural killer cell', 3313, 'NK cell'), ('GO_0005634', 'nucleus', 3313, 'NK'), ('CL_0000623', 'natural killer cell', 3421, 'NK cells'), ('CL_0000623', 'natural killer cell', 3447, 'NK cell'), ('CL_0000084', 'T cell', 3485, 'T cell'), ('CL_0000893', 'thymocyte', 3562, 'thymocyte'), ('UBERON_0002370', 'thymus', 3581, 'thymus'), ('CHEBI_59132', 'antigen', 3686, 'antigen'), ('CL_0000236', 'B cell', 3714, 'B cell'), ('CHEBI_33250', 'atom', 3777, 'BCG'), ('CHEBI_17089', 'glycoprotein', 3821, 'glycoprotein'), ('PR_000005170', 'CD37 molecule', 3897, 'CD45RO'), ('PR_000011040', 'nuclear receptor coactivator 1', 3906, 'cluster of differentiation antigen 45 RO'), ('CHEBI_59132', 'antigen', 3933, 'antigen'), ('PR_000005890', 'crooked neck-like protein 1', 3948, 'CRP'), ('UBERON_0001977', 'blood serum', 4083, 'serum'), ('CHEBI_60425', 'amyloid fibril', 4089, 'amyloid'), ('CHEBI_27300', 'vitamin D', 4122, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4138, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4165, 'vitamin A')]	0	['caption (table-wrap): table 6\n\neffects micronutrient supplementation immune vaccine responses (human studies)1type malnutrition type immune functioneffects supplementation immune system (reference)vitamin a\u2003epithelial function● high-dose vas 6 mo age decreases death infections measles diarrheal diseases (290)● vas context hiv infection respiratory tract infections outcomes (105,263,290–292)● (105)● abnormal dual-sugar (lactulose, mannitol) intestinal permeability serum retinol (293) normalized supplementation va-deficient individuals (294) (295,296)● symptomatology high-dose vas acute respiratory tract infections (105) restored mucus production\u2003innate physiologic barriers● vas crp, saa, and/or agp concentrations among children subclinical vad (297–299)● crp agp men va stores va (300)\u2003macrophage function● monocyte (301)● decreased tnf-α concentrations children (301) men (106)● decreased ifn-γ concentrations children (302) pregnant women (303)● il-10 concentrations children (105,301)  (106,303,304)\u2003neutrophil function● neutrophil phagocytosis latex beads va-deficient children single dose va (305)● neutrophil phagocytosis e. coli men va stores va (300)\u2003nk cell function● increase nk cells hiv-infected children supplemented va (105)● nk cell men va supplemental va; however, positive va stores peripheral blood nk cells (300)\u2003t cell function● lymphocyte counts, cd4 counts (105)● cd4:cd8 ratios supplementation (306)● increase naive cd4 cells supplementation; higher memory cd8, cd45ro (307)● higher mitogen-induced il-2, il-4, tnf response supplementation (106)\u2003b cell function● supplementation measles vaccine response (308) response individuals baseline titers (103)● oral polio vaccination● supplemented children igg1 responses dtp, minor igg3 response, igg2 igg4 (309)● bcg vaccine va-supplemented children, response va-supplemented boys 2 mo (310)● antibody responses vaccines (measles vaccine 9 mo age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response ppd boys (103) hospitalized children (105)zinc\u2003epithelial function● zn supplementation children lactulose:mannitol excretion ratio (311) (312,313) studies; ratio infected children zn supplemental zn (314)\u2003innate physiologic ● zn-supplemented children higher serum c3 (315)\u2003nk cell function● children diarrhea supplemented zn supplementation increase nk cells (316)● nk cell activity elderly (317)\u2003t cell function● cd4+ cell count patients (318)● thymocyte count thymus (319)● thymulin activity (320)● zn supplementation dth tb antigen [reviewed (103)]\u2003b cell function● zn supplementation mothers bcg response children (321)\nagp, α1-acid glycoprotein; bcg, bacille calmette-guérin; cd, cluster differentiation; cd45ro cluster antigen 45 ro; crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, serum amyloid a; tb, tuberculosis; va, vad,  deficiency; vas,  supplementation.']
S26-PMC4452099	PMC4452099	6/2015	S26-PMC4452099	['STILL, on average, 13% of all dietary Vitamin D among Adult danes was ESTIMATED to have come from the fortified Margarine [20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 70)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('CHEBI_6784', 'mestranol', 112, 'margarine')]	0	['still, average, 13% dietary  among  danes come fortified margarine [20].']
S77-PMC4452099	PMC4452099	6/2015	S77-PMC4452099	['when assessing the benefits of Food fortification, MOSTLY medium SCALE clinical TRIALS are conducted, SO FAR SHOWING that Vitamin D-fortified Foods improve Vitamin D status in Adults [22].']	[('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 109)]	4	[('CHEBI_33290', 'food', 31, 'food'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33290', 'food', 142, 'foods'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]	0	['food fortification, medium conducted, -fortified foods  status  [22].']
S79-PMC4452099	PMC4452099	6/2015	S79-PMC4452099	['additionally, in finland, where Vitamin D since february 2003 has been added to all liquid Milk products, Margarine and butter, before-after comparisons in various cohorts SHOWED that fortification has improved the Vitamin D status in both children and Adults [23,24].']	[('INCOMPLETE_EVIDENCE', 172)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001913', 'milk', 91, 'milk'), ('CHEBI_6784', 'mestranol', 106, 'margarine'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0007023', 'adult organism', 253, 'adults')]	0	['additionally, finland,  february 2003 added liquid milk products, margarine butter, before-after comparisons cohorts fortification  status children  [23,24].']
S98-PMC4499946	PMC4499946	7/2015	S98-PMC4499946	['our PREVIOUS pharmacokinetic FINDINGS among Pregnant women in dhaka [16,40] HAVE GENERALLY BEEN CONSISTENT with published ESTIMATES of the Vitamin D-to-25(Oh)D dose–response RELATIONSHIP in non-Pregnant Adults (i.e., an APPROXIMATELY 0.7 nmol/l increase in 25(Oh)D at steady state for each 1 μg/day of Vitamin D3[41,42]).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 81), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 220)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnant'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 155, 'OH)D'), ('GO_0007565', 'female pregnancy', 194, 'pregnant'), ('UBERON_0007023', 'adult organism', 203, 'adults'), ('CHEBI_63056', 'zinc cation', 257, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_33279', 'vitamin D5', 302, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 302, 'vitamin D3')]	0	['pharmacokinetic among pregnant women dhaka [16,40] -to-25(oh)d dose–response non-pregnant  (i.e., 0.7 nmol/l increase 25(oh)d steady μg/day vitamin d3[41,42]).']
S2-PMC4595656	PMC4595656	10/2015	S2-PMC4595656	['a NUMBER OF STUDIES to date have investigated the EFFECTS of early-Life Vitamin D deprivation on Adult hippocampus in Animals and Humans, and there is a growing BODY OF EVIDENCE to SUGGEST a ROLE for this hormone in the development of selected hippocampal functions such as latent inhibition and hole board Habituation in Rats.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 191)]	5	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0007023', 'adult organism', 97, 'adult'), ('NCBITaxon_33208', 'Metazoa', 118, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('GO_0046959', 'habituation', 307, 'habituation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 322, 'rats')]	0	['early-life  deprivation  hippocampus animals humans, hormone selected hippocampal functions latent inhibition hole board habituation rats.']
S18-PMC4632418	PMC4632418	10/2015	S18-PMC4632418	['IN ACCORDANCE WITH these definitions, EVEN middle-age Adults are at equally high RISK with elder and children for Vitamin D deficiency and insufficiency worldwide [6].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 81)]	3	[('UBERON_0007023', 'adult organism', 54, 'adults'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]	0	['definitions, middle-age  elder children  [6].']
S117-PMC4684854	PMC4684854	12/2015	S117-PMC4684854	['finally, Gestational Vitamin D levels MAY IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the development of Adult onset multiple sclerosis [94].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('GO_0007565', 'female pregnancy', 9, 'gestational'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('UBERON_0007023', 'adult organism', 178, 'adult')]	0	['finally, gestational  levels   pregnancy  onset sclerosis [94].']
S138-PMC4684854	PMC4684854	12/2015	S138-PMC4684854	['with EVIDENCE that a major proportion of the Adult population [38], particularly in northern climates [39], is POTENTIALLY deficient in Vitamin D, it APPEARS that, at minimum, one out of every few expectant mothers will have INADEQUATE levels of this ESSENTIAL Nutrient.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 111), ('ANOMALY_CURIOUS_FINDING', 150), ('IMPORTANT_CONSIDERATION', 225), ('IMPORTANT_CONSIDERATION', 251)]	5	[('UBERON_0007023', 'adult organism', 45, 'adult'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33284', 'nutrient', 261, 'nutrient')]	0	['proportion  population [38], northern climates [39], that, minimum, expectant mothers levels nutrient.']
S96-PMC4714725	PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]	0	['ab, micronutrients herbal supplements\nthere dietary supplementation vitamins, minerals, herbs, spices diabetes, regarding long-term antioxidant supplements  c carotene.c alcohol\nadults diabetes drink alcohol moderation (no drink day  women drinks day  men).c\nalcohol consumption place people diabetes delayed hypoglycemia, insulin secretagogues.']
S36-PMC4764019	PMC4764019	1/2016	S36-PMC4764019	['pregnancy complications\none of the most STRIKING and SURPRISING findings to emerge from the finnish Birth cohort study DESCRIBED PREVIOUSLY was the fact that 20+ years after their infancy exposure to Vitamin D, women in the cohort who, as Adults, became Pregnant exhibited an APPROXIMATE 50% reduction in risk of Preeclampsia in their own first Pregnancies,8once again, relative to women who had not received the then RECOMMENDED 2000 iu/d of Vitamin D in infancy.']	[('ANOMALY_CURIOUS_FINDING', 40), ('ANOMALY_CURIOUS_FINDING', 53), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 418)]	6	[('GO_0007567', 'parturition', 100, 'birth'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 239, 'adults'), ('GO_0007565', 'female pregnancy', 254, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 313, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 345, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D')]	0	['pregnancy complications\none 20+ infancy exposure women who, became pregnant 50% reduction preeclampsia pregnancies,8once again, relative women received 2000 iu/d  infancy.']
S24-PMC4785305	PMC4785305	3/2016	S24-PMC4785305	"['[""""ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women\'s survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\\n\\nVitamin d replacement guidelines during Pregnancy\\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially.""""]']"	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]	0	"['[""""association maternn neonatal outcomes\\nlow maternal 25(oh)d levels fetal programming, events neonates, resulting gestational age (sga) birth,1923and childhood, muscle bone mass offspring 4 9\\u2005years.2425this vitamin fetal musculoskeletal integrity, neonatal bone accrual, proteins placental calcium transport.26recently, southampton women*s survey (sws) maternal 25(oh)d placental amino acid transporters expression, transport nutrients fetus.27furthermore, vitamin fetal muscle motor unit size, muscle mass birth.25it fetal bone peak boss, adult bone mineral content hip geometry, fracture life.2628\\n\\nvitamin replacement pregnancy\\nthe guidelineng vitamin replacement supplementation pregnancy substantially.""""]']"
S127-PMC4829940	PMC4829940	5/2016	S127-PMC4829940	['HOWEVER, a FEW other STUDIES have explored RELATIONSHIPS between Vitamin D supplementation or circulating 25(Oh)D and methylation at a few Cpg Sites in two to four candidate Genes in Adults[18],[46], and one Genome-wide Dna Methylation study explored ASSOCIATION with Vitamin D deficiency in african children[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D'), ('SO_0000036', 'matrix_attachment_site', 139, 'CpG sites'), ('SO_0000704', 'gene', 174, 'genes'), ('UBERON_0007023', 'adult organism', 183, 'adults'), ('SO_0001026', 'genome', 208, 'genome'), ('GO_0006306', 'DNA methylation', 220, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D')]	0	['however,  supplementation circulating 25(oh)d methylation cpg sites four genes [18],[46], genome-wide dna methylation  african children[17].']
S0-PMC4832516	PMC4832516	10/2015	S0-PMC4832516	['season of Birth is ASSOCIATED with Birth weight, Pubertal timing, Adult body size and educational attainment: a uk biobank study\n\nabstract\nseason of Birth, a marker of in utero Vitamin D exposure, HAS BEEN ASSOCIATED with a WIDE RANGE of health outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('GO_0007567', 'parturition', 35, 'birth'), ('GO_0007567', 'parturition', 49, 'pubertal'), ('UBERON_0007023', 'adult organism', 66, 'adult'), ('GO_0007567', 'parturition', 149, 'birth'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]	0	['season birth birth weight, pubertal timing,  educational attainment: uk biobank study\n\nabstract\nseason birth, utero  exposure, outcomes.']
S139-PMC4832516	PMC4832516	10/2015	S139-PMC4832516	['WHILE the ASSOCIATIONS between season of Birth, or ESTIMATED Antenatal sunshine exposure, with Birth weight are CONSISTENT with experimental EFFECTS of in utero Vitamin D exposure on fetal growth, differing patterns of seasonality and INDEPENDENT ASSOCIATIONS SUGGEST that OTHER mechanisms MAY LINK season of Birth to Adult height and also puberty timing in women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 247), ('INCOMPLETE_EVIDENCE', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 290), ('SUPERFICIAL_RELATIONSHIP', 294)]	12	[('GO_0007567', 'parturition', 41, 'birth'), ('GO_0007567', 'parturition', 61, 'antenatal'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007567', 'parturition', 309, 'birth'), ('UBERON_0007023', 'adult organism', 318, 'adult')]	0	['season birth, antenatal sunshine exposure, birth utero  exposure fetal growth, seasonality mechanisms season birth  height puberty timing women.']
S158-PMC4846845	PMC4846845	4/2016	S158-PMC4846845	['higher levels of Vitamin D is ASSOCIATED with higher fasting Insulin, Cholesterol, and Triglyceride concentrations in Adults [120,121,122,123,124].']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('PR_000045358', 'insulin family protein', 61, 'insulin'), ('CHEBI_16113', 'cholesterol', 70, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 87, 'triglyceride'), ('UBERON_0007023', 'adult organism', 118, 'adults')]	0	['higher levels  higher fasting insulin, cholesterol, triglyceride concentrations  [120,121,122,123,124].']
S0-PMC4859539	PMC4859539	5/2016	S0-PMC4859539	['circulating Cathelicidin concentrations in a cohort of healthy children: INFLUENCE of age, body composition, gender and Vitamin D status\n\nabstract\nCathelicidin is an Antimicrobial peptide whose circulating levels are RELATED to Vitamin D status in Adults.']	[('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 217)]	2	[('CHEBI_3461', 'Casuarictin', 12, 'Cathelicidin'), ('PR_000004907', 'complement component C7', 12, 'Cathelicidin'), ('CHEBI_28384', 'vitamin K', 120, 'Vitamin D'), ('PR_000004907', 'complement component C7', 147, 'Cathelicidin'), ('CHEBI_65381', 'albizoside C', 166, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('UBERON_0007023', 'adult organism', 248, 'adults')]	0	['circulating cathelicidin concentrations healthy children: age, composition, gender vitamin status\n\nabstract\ncathelicidin antimicrobial peptide whose circulating levels  status .']
S13-PMC4859539	PMC4859539	5/2016	S13-PMC4859539	['PREVIOUS STUDIES have focused on Cathelicidin and Vitamin D concentrations in patient populations affected by various illnesses or diseases [6], such as tuberculosis [7], pneumonia [8], sepsis [9], hiv [10–12], and end-stage Renal disease hemodialysis [13], as well as healthy Adult populations [14–19].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('PR_000006009', 'alpha-catulin', 33, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0002113', 'kidney', 225, 'renal'), ('UBERON_0007023', 'adult organism', 277, 'adult')]	0	['previous cathelicidin  concentrations patient populations illnesses diseases [6], tuberculosis [7], pneumonia [8], sepsis [9], hiv [10–12], end-stage renal disease hemodialysis [13], healthy  populations [14–19].']
S420-PMC4896250	PMC4896250	4/2016	S420-PMC4896250	['after adjustment for CONFOUNDING FACTORS, including age, smoking, alcohol drinking, exercise, and Vitamin D levels, high bmi (≥30 kg/m2) (or = 4.241, 95% ci: 1.60–11.24), high wc (≥80 cm) (or = 2.062, 95% ci: 1.08–3.94), and high bf percentage (q4) (or = 2.073, 95% ci: 1.22–3.52) were shown to be significantly ASSOCIATED with ad in young Adult women.']	[('PROBLEM_COMPLICATION', 21), ('SUPERFICIAL_RELATIONSHIP', 312)]	2	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0007023', 'adult organism', 340, 'adult')]	0	['adjustment factors, age, smoking, alcohol drinking, exercise,  levels, bmi (≥30 kg/m2) (or = 4.241, 95% ci: 1.60–11.24), wc (≥80 cm) (or = 2.062, 95% ci: 1.08–3.94), bf percentage (q4) (or = 2.073, 95% ci: 1.22–3.52) ad young  women.']
S8292-PMC4896250	PMC4896250	4/2016	S8292-PMC4896250	['objective\nwe AIMED TO INVESTIGATE WHETHER Vitamin D insufficiency in asthmatic Adults ASSOCIATES with atopy, poor asthma Control, and more frequent Respiratory Tract infections, and WHETHER these patients CAN BENEFIT from Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 209)]	7	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('GO_0065007', 'biological regulation', 121, 'control'), ('UBERON_0000065', 'respiratory tract', 148, 'respiratory tract'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]	0	['objective\nwe  asthmatic  atopy, asthma control, respiratory tract infections, patients  supplementation.']
S16-PMC4897157	PMC4897157	5/2016	S16-PMC4897157	['RECENT REPORTS HAVE SHOWN that Vitamin D deficiency is very common in korea9), particularly in young Adults10).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0007023', 'adult organism', 101, 'adults10')]	0	['recent  korea9), young ).']
S98-PMC4903143	PMC4903143	5/2016	S98-PMC4903143	['in addition, Gestational Vitamin D levels MAY EVEN IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the Development Of Adult-onset multiple Sclerosis [33].']	[('INCOMPLETE_EVIDENCE', 42), ('ANOMALY_CURIOUS_FINDING', 46), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adult'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0048513', 'animal organ development', 172, 'development of ... sclerosis'), ('UBERON_0007023', 'adult organism', 187, 'adult')]	0	['addition, gestational  levels   pregnancy -onset sclerosis [33].']
S1-PMC4934634	PMC4934634	11/2015	S1-PMC4934634	['RECENT RESEARCH has SUGGESTED that Vitamin D MAY exert a broad RANGE of ROLES throughout the Human Life Cycle starting from Reproduction to Adult chronic disease risk.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('SUPERFICIAL_RELATIONSHIP', 72)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('UBERON_0000104', 'life cycle', 99, 'life cycle'), ('GO_0007049', 'cell cycle', 104, 'cycle'), ('GO_0000003', 'reproduction', 124, 'reproduction'), ('UBERON_0007023', 'adult organism', 140, 'adult')]	0	['recent  exert broad throughout human life cycle reproduction  chronic disease risk.']
S47-PMC4934634	PMC4934634	11/2015	S47-PMC4934634	['THE CURRENT REVIEW is FOCUSED on the EFFECTS of Vitamin D on numerous aspects of Reproduction including Male and Female Fertility, Pregnancy, and infant outcomes as well as childhood and Adult disease (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 37)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0000003', 'reproduction', 81, 'reproduction'), ('GO_0007618', 'mating', 104, 'male ...'), ('GO_0007567', 'parturition', 113, 'female fertility'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('UBERON_0007023', 'adult organism', 187, 'adult')]	0	[' aspects reproduction male female fertility, pregnancy, infant outcomes childhood  disease (figure 1).']
S147-PMC4949006	PMC4949006	7/2016	S147-PMC4949006	['it HAS BEEN IDENTIFIED as a Nutrient of PUBLIC HEALTH CONCERN by the us department of health and Human services.104\nNUMEROUS STUDIES HAVE SHOWN a prevalence of vitamin d levels of less than 50 nmol/l in 30% to 96% of Pregnant women, increasing with latitude and with nonwhite race.105–111a study done using archived samples of Cord Blood in denmark SHOWED an increased risk of developing schizophrenia with either elevated or low levels of Vitamin D. it was HYPOTHESIZED that IF all the infants COULD have been Born with normal levels there would have been a reduction of 43% in the incidence of schizophrenia among the Adults.112there is also an ASSOCIATION of Vitamin D deficiency and Insulin resistance,113which was reversed with a single injection of the vitamin114(not approved in the united states).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 458), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('INCOMPLETE_EVIDENCE', 495), ('SUPERFICIAL_RELATIONSHIP', 647)]	10	[('CHEBI_33284', 'nutrient', 28, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 97, 'Human'), ('GO_0007565', 'female pregnancy', 217, 'pregnant'), ('UBERON_0002240', 'spinal cord', 327, 'cord'), ('UBERON_0000178', 'blood', 332, 'blood'), ('CHEBI_28384', 'vitamin K', 440, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 440, 'Vitamin D'), ('GO_0007567', 'parturition', 511, 'born'), ('UBERON_0007023', 'adult organism', 620, 'adults'), ('CHEBI_27300', 'vitamin D', 662, 'vitamin D'), ('PR_000045358', 'insulin family protein', 687, 'insulin')]	0	['nutrient us department human services.104\nnumerous vitamin levels 50 nmol/l 30% 96% pregnant women, latitude nonwhite race.105–111a done using archived samples cord blood denmark schizophrenia levels vitamin d. infants born normal levels reduction 43% schizophrenia among .112there  insulin resistance,113which single injection vitamin114(not approved united states).']
S48-PMC4969253	PMC4969253	8/2016	S48-PMC4969253	['vitamin a-ra and Postnatal Airway disease\na NUMBER OF epidemiological STUDIES in children and Adult subjects have LINKED Vitamin A status with chronic Airway diseases.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 114)]	2	[('GO_0007567', 'parturition', 17, 'postnatal'), ('UBERON_0001005', 'respiratory airway', 27, 'airway'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('UBERON_0001005', 'respiratory airway', 151, 'airway')]	0	['vitamin a-ra postnatal airway disease\na epidemiological children  subjects  status chronic airway diseases.']
S80-PMC4969253	PMC4969253	8/2016	S80-PMC4969253	['the IMPACT of Prenatal disruption of ra signaling in Adult Airway structure and function HAS BEEN WELL DEMONSTRATED using a MODEL of Vitamin A deficiency in Mice [14].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 98), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 124)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('UBERON_0007023', 'adult organism', 53, 'adult'), ('UBERON_0001005', 'respiratory airway', 59, 'airway'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 157, 'mice')]	0	['prenatal ra signaling  airway structure using  mice [14].']
S82-PMC4969253	PMC4969253	8/2016	S82-PMC4969253	['REMARKABLY, IF returned to normal Vitamin A diet later in Gestation and throughout their Postnatal Life, Adult Mice show a markedly thick Airway Sm layer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007567', 'parturition', 89, 'postnatal'), ('UBERON_0000104', 'life cycle', 99, 'life'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 111, 'mice'), ('UBERON_0001005', 'respiratory airway', 138, 'airway'), ('UBERON_0001290', 'proximal straight tubule', 145, 'SM')]	0	['remarkably, returned normal  diet gestation throughout postnatal life,  mice thick airway sm layer.']
S19-PMC4971719	PMC4971719	8/2016	S19-PMC4971719	['for instance, a systematic review and meta-analysis of observational studies involving 31,424 non-Pregnant Adults FOUND low Vitamin D levels to be significantly ASSOCIATED with clinical diagnoses of depression [13].']	[('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 161)]	2	[('GO_0007565', 'female pregnancy', 98, 'pregnant'), ('UBERON_0007023', 'adult organism', 107, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]	0	['instance, meta-analysis 31,424 non-pregnant   levels diagnoses depression [13].']
S70-PMC4976416	PMC4976416	7/2016	S70-PMC4976416	['[51] in a healthy Adult who had been on a normal diet it would take an ESTIMATED 4 years to fully deplete body stores of Vitamin E.[52]\n\ntopical vitamin E in dermatology\ntopical Vitamin E has emerged as a popular treatment for a number of skin disorders OWING TO its antioxidant properties.']	[('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 254)]	2	[('UBERON_0007023', 'adult organism', 18, 'adult'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 153, 'E'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin E')]	0	['[51] healthy  normal diet 4 deplete stores .[52]\n\ntopical vitamin e dermatology\ntopical  treatment skin disorders antioxidant properties.']
S82-PMC4976416	PMC4976416	7/2016	S82-PMC4976416	['Vitamin E being a fat-soluble Vitamin, administration of a dose higher than daily REQUIREMENT results in accumulation inside the body, resulting in hypervitaminosis e. healthy Adults taking Vitamin E daily at a dose of 100 mg for more than 1 year are LIKELY to get hypervitaminosis E, manifesting as reduced Platelet Aggregation and interference with Vitamin K Metabolism resulting in bleeding tendencies.']	[('IMPORTANT_CONSIDERATION', 82), ('PROBABLE_UNDERSTANDING', 251)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin E'), ('CHEBI_33229', 'vitamin (role)', 30, 'vitamin'), ('UBERON_0007023', 'adult organism', 176, 'adults'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 282, 'E'), ('CL_0000233', 'platelet', 308, 'platelet'), ('GO_0070527', 'platelet aggregation', 308, 'platelet aggregation'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin K'), ('GO_0007601', 'visual perception', 351, 'vitamin K'), ('GO_0008152', 'metabolic process', 361, 'metabolism')]	0	['vitamin e fat-soluble vitamin, administration dose higher daily results accumulation inside body, resulting hypervitaminosis e. healthy   daily dose 100 mg year get hypervitaminosis e, manifesting platelet aggregation  metabolism resulting bleeding tendencies.']
S345-PMC4989298	PMC4989298	8/2016	S345-PMC4989298	['HOWEVER, SEVERAL STUDIES report SUBOPTIMAL Vitamin D status in large parts of the population of children and Adults.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 32)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0007023', 'adult organism', 109, 'adults')]	0	['however,  status parts population children .']
S10-PMC4998950	PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]	0	['environmental genetic important,1although asd intellectual disability origins.2,3\nin high-latitude countries sweden, children mothers dark complexion asd intellectual disability.3because women vitamin levels melanin absorption uvb radiation, maternal  asd offspring.4,5indeed, experimentally induced  pregnant dams foetal neurodevelopment behaviour  offspring rats,4and neonatal  levels children asd siblings.6\nearly life  asd, lacking.4maternal hypovitaminosis treatable, warranted.']
S80-PMC5028238	PMC5028238	10/2016	S80-PMC5028238	['this would PROTECT Individuals from developing rickets (a Vitamin D deficiency condition that results in bone softening and malformations) and osteomalacia (an Adult form of rickets).17\ncertain Dhcr7 variants were found to be evolutionarily favored in northern climates, including europe and asia28suggesting a selective pressure and a PLAUSIBLE heterozygote advantage for those variants.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 336)]	2	[('NCBITaxon_1', 'root', 19, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 160, 'adult'), ('PR_000006474', 'ATP-dependent RNA helicase A', 194, 'DHCR7')]	0	['individuals rickets (a  condition results bone softening malformations) osteomalacia (an  form rickets).17\ncertain dhcr7 variants evolutionarily northern climates, europe asia28suggesting pressure heterozygote variants.']
S0-PMC5039809	PMC5039809	10/2016	S0-PMC5039809	['maternal Serum Retinol and Β-Carotene concentrations and neonatal bone mineralization: results from the southampton women’s survey cohort\n\nabstract\nbackground: studies in older Adults and Animals have SUGGESTED CONTRASTING RELATIONS between bone health and DIFFERENT Vitamin A Compounds.']	[('INCOMPLETE_EVIDENCE', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('SUPERFICIAL_RELATIONSHIP', 223), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	4	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_26536', 'retinoic acid', 15, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 27, 'β-carotene'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('NCBITaxon_33208', 'Metazoa', 188, 'animals'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin A'), ('CHEBI_36357', 'polyatomic entity', 277, 'compounds')]	0	['maternal serum retinol β-carotene concentrations neonatal bone mineralization: results southampton women’s survey cohort\n\nabstract\nbackground: older  animals bone  compounds.']
S17-PMC5039809	PMC5039809	10/2016	S17-PMC5039809	['THERE IS EVIDENCE in Adults that Vitamin A intake is ASSOCIATED with measures of bone health, BUT NOTABLY, the DIFFERENT forms of dietary Vitamin A HAVE BEEN demonstrated to have OPPOSING ASSOCIATIONS with fracture risk (6).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 94), ('ANOMALY_CURIOUS_FINDING', 98), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 188)]	9	[('UBERON_0007023', 'adult organism', 21, 'adults'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]	0	['  intake bone health, notably, forms dietary  fracture (6).']
S115-PMC5039809	PMC5039809	10/2016	S115-PMC5039809	['the RELATIONS between Vitamin A nutrition, assessed by an ffq or Serum measurements, and fracture risk or bmd in Adults are INCONSISTENT (18), BUT in a RECENT meta-analysis wu et al.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('UBERON_0007023', 'adult organism', 113, 'adults')]	0	[' nutrition, ffq serum measurements, fracture bmd  (18), meta-analysis wu et al.']
S67-PMC5045784	PMC5045784	10/2016	S67-PMC5045784	['the ASSOCIATION between low Vitamin D levels and Respiratory morbidity as SEEN in older children and Adults MAY BE DUE TO DIFFERENT pathology than that SEEN in bpd, which is characterized by Alveolar simplification and impaired septation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('INCOMPLETE_EVIDENCE', 152)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 49, 'respiratory'), ('UBERON_0007023', 'adult organism', 101, 'adults'), ('UBERON_0003215', 'alveolus', 191, 'alveolar')]	0	[' levels respiratory morbidity older children  pathology bpd, alveolar simplification septation.']
S153-PMC5062906	PMC5062906	10/2016	S153-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation in Soma and germline of Adult g1and g2males in a parent and grandparent of origin-DEPENDENT manner\nwe INVESTIGATED WHETHER Vitamin D depletion AFFECTS Dna Methylation state at Imprinted Genes in g1and g2males and WHETHER these differences are LINKED to the developmental changes described above.']	[('SUPERFICIAL_RELATIONSHIP', 134), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('SUPERFICIAL_RELATIONSHIP', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0044297', 'cell body', 55, 'soma'), ('UBERON_0007023', 'adult organism', 76, 'adult'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0006306', 'DNA methylation', 203, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 228, 'imprinted'), ('SO_0000704', 'gene', 238, 'genes')]	0	['maternal  depletion alters dna methylation soma germline  g1and g2males parent grandparent origin-dependent manner\nwe  depletion dna methylation imprinted genes g1and g2males developmental changes above.']
S118-PMC5129897	PMC5129897	10/2016	S118-PMC5129897	"['[""""“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\\xa0weeks\' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\\xa0y.83\\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\\n\\nall-cause mortality rate\\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment.""""]']"	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]	0	"['[""""“the results thn supplementation pregnancy reduces preterm birth, birth weight, dental caries infancy, neonatal infectious diseases respiratory infections sepsis.”81furthermore, fetal origins pediatric ault disease, gestationn indices life.82for example, maternn levels 18\\xa0weeks* pregnancy outcomes progeny gestatamin higher lung 6-year-old offspring, neurocognitive age 10\\xa0years, eating disorders adolescence, peak bone mass 20\\xa0y.83\\na cohat vitamin reduces exacerbations asthma.84\\n\\nall-cause mortality rate\\ngarland colleagues85presented meta-analysis 32 all-cause mortality rate respect 25(oh)d concentration enrollment.""""]']"
S15-PMC5146866	PMC5146866	12/2016	S15-PMC5146866	['HOWEVER, the clinical practice guidelines published by the Endocrine society RECOMMENDS that 30\xa0ng/ml of Vitamin D in children and Adults SHOULD BE CONSIDERED sufficient and classifies levels below 20\xa0ng/ml (50\xa0nmol/l) and 21–29\xa0ng/ml (55–75\xa0nmol/l) as deficient and insufficient, respectively [10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 77), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 148)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 59, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 131, 'adults')]	0	['however, endocrine society 30\xa0ng/ml  children  classifies levels 20\xa0ng/ml (50\xa0nmol/l) 21–29\xa0ng/ml (55–75\xa0nmol/l) insufficient, respectively [10].']
S79-PMC5146866	PMC5146866	12/2016	S79-PMC5146866	['IMPORTANTLY, the upper limit of Vitamin D that is defined as sufficient [8] COULD BE SUBOPTIMAL BECAUSE Vitamin D levels of <30\xa0ng/ml have been ASSOCIATED with increased secretion of intact Parathyroid hormone and reduced Intestinal calcium absorption in healthy Adults [22,23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 85), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 190, 'parathyroid'), ('UBERON_0000160', 'intestine', 222, 'intestinal'), ('UBERON_0007023', 'adult organism', 263, 'adults')]	0	['importantly, upper  [8]  levels <30\xa0ng/ml secretion intact parathyroid hormone intestinal calcium absorption healthy  [22,23].']
S80-PMC5146866	PMC5146866	12/2016	S80-PMC5146866	['WHILE a Vitamin D level of 20\xa0ng/ml IS CONSIDERED sufficient, maintenance of 30\xa0ng/ml is RECOMMENDED for better health in children and Adults [24] DESPITE the LACK OF CLEAR EVIDENCE of an OPTIMAL concentration of Vitamin D for bone and general health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]	0	[' 20\xa0ng/ml sufficient, maintenance 30\xa0ng/ml children  [24] concentration  bone health.']
S21-PMC5155676	PMC5155676	12/2016	S21-PMC5155676	['in nonpregnant Adults, baseline 25(Oh)D concentration, body weight/adiposity and age are IMPORTANT DETERMINANTS of the incremental rise in 25(Oh)D after Vitamin D supplementation (13,14).']	[('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('UBERON_0007023', 'adult organism', 15, 'adults'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 38, 'D'), ('CHEBI_30778', 'gallic acid', 139, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 145, 'D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]	0	['nonpregnant baseline 25(oh)d concentration, weight/adiposity age incremental rise 25(oh)d  supplementation (13,14).']
S113-PMC5155676	PMC5155676	12/2016	S113-PMC5155676	['IMPORTANTLY, the difference between the 25(Oh)D achieved at 34 weeks of Gestation in women randomized to Placebo compared with Cholecalciferol decreased with increasing baseline 25(Oh)D. this is CONSISTENT with PREVIOUS STUDIES in Adults, which HAVE SHOWN that the incremental response to Vitamin D supplementation is higher in Vitamin D insufficient than replete subjects (13,14) and that the increase in 25(Oh)D relative to supplementation dose is negatively ASSOCIATED with dose of vitamin D supplement (26).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 461)]	5	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('GO_0007565', 'female pregnancy', 72, 'gestation'), ('CHEBI_26130', 'biological pigment', 105, 'placebo'), ('CHEBI_52550', 'theopalauamide', 127, 'cholecalciferol'), ('CHEBI_33010', 'chromide(1-)', 180, '(OH)D'), ('UBERON_0007023', 'adult organism', 231, 'adults'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 493, 'D')]	0	['importantly, 25(oh)d achieved 34 weeks gestation women placebo cholecalciferol decreased baseline 25(oh)d. incremental response  supplementation higher  replete subjects (13,14) increase 25(oh)d relative supplementation dose dose vitamin supplement (26).']
S123-PMC5155676	PMC5155676	12/2016	S123-PMC5155676	['data from healthy and hospitalized Adults have SIMILARLY SHOWN that older Individuals achieve a higher 25(Oh)D after Vitamin D supplementation (13,32).']	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('NCBITaxon_1', 'root', 74, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 105, '('), ('PR_000006444', 'diacylglycerol kinase delta', 109, 'D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]	0	['data healthy hospitalized  older individuals achieve higher 25(oh)d  supplementation (13,32).']
S55-PMC5322422	PMC5322422	2/2017	S55-PMC5322422	['first, Placental Transfer of Vitamin K is LIMITED with extremely low Cord concentrations (<0.05\u2009 μ g/l) compared to Adult levels [1].']	[('INCOMPLETE_EVIDENCE', 42)]	1	[('UBERON_0001987', 'placenta', 7, 'placental'), ('GO_0006412', 'translation', 17, 'transfer'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin K'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0007023', 'adult organism', 116, 'adult')]	0	['first, placental transfer  cord concentrations (<0.05\u2009 μ g/l)  levels [1].']
S136-PMC5340372	PMC5340372	3/2017	S136-PMC5340372	['second, our PREVIOUS report CONCLUDED that relatively low Vitamin D levels were COMMON in the patch population sample of children and young Adults with an inverse CORRELATION between 25(Oh)D level and age being SHOWN HERE [51].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 211), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 140, 'adults'), ('CHEBI_33010', 'chromide(1-)', 185, '(OH)D')]	0	['second,  levels patch population sample children young  25(oh)d age [51].']
S41-PMC5372327	PMC5372327	3/2017	S41-PMC5372327	['in Adults, Vitamin D insufficiency increases the RISK of SEVERE infections [28], BUT the results from intervention trials are CONFLICTING [29].']	[('IMPORTANT_CONSIDERATION', 49), ('IMPORTANT_CONSIDERATION', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126)]	4	[('UBERON_0007023', 'adult organism', 3, 'adults'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]	0	[' infections [28], results [29].']
S52-PMC5372327	PMC5372327	3/2017	S52-PMC5372327	['Vitamin D trials are RARE and they have not been able to SUPPORT beneficial EFFECTS of Vitamin D supplementation on Cognitive functions among Adults [47,48].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0050890', 'cognition', 116, 'cognitive'), ('UBERON_0007023', 'adult organism', 142, 'adults')]	0	['vitamin able  supplementation cognitive functions among  [47,48].']
S30-PMC5405075	PMC5405075	4/2017	S30-PMC5405075	['Gestational Vitamin D has now been LINKED to a variety of diseases such as osteoporosis, Autoimmune disorders, altered Brain Development and Adult mental health, Food allergies, and asthma (17,29,31–33).']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('GO_0007420', 'brain development', 119, 'brain development'), ('UBERON_0000955', 'brain', 119, 'brain'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('CHEBI_33290', 'food', 162, 'food')]	0	['gestational  diseases osteoporosis, autoimmune disorders, altered brain  mental health, food allergies, asthma (17,29,31–33).']
S16-PMC5418719	PMC5418719	5/2017	S16-PMC5418719	['WHILE Breast Milk Feeding is currently RECOMMENDED as a source of early nutrition in full and preterm infants, an infant diet with Breast Milk alone does not contain enough Vitamin D. the definition of Vitamin D sufficiency in preterm infants is STILL CONTROVERSIAL; optimal Vitamin D status is BASED ON the Vitamin D concentrations for multiple health outcomes in Adults with a target value for 25(Oh)D levels >30\xa0ng/ml [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 39), ('IMPORTANT_CONSIDERATION', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('QUESTION_ANSWERED_BY_THIS_WORK', 295), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('UBERON_0001348', 'brown adipose tissue', 6, 'breast milk'), ('GO_0007614', 'short-term memory', 13, 'milk'), ('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001348', 'brown adipose tissue', 131, 'breast milk'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('UBERON_0007023', 'adult organism', 365, 'adults'), ('CHEBI_71657', 'versiconol acetate', 396, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 396, '25(OH ... D')]	0	['breast milk feeding nutrition preterm infants, infant diet breast milk contain . definition  preterm infants controversial;  status  concentrations outcomes  25(oh)d levels >30\xa0ng/ml [8].']
S20-PMC5426325	PMC5426325	4/2017	S20-PMC5426325	['GIVEN that low bone Mineral density (bmd) is PREDICTIVE of increased fracture risk, AS SHOWN in both case–control and prospective studies – THOUGH principally in Adults(13–20)– maternal Vitamin D insufficiency MAY POTENTIALLY also INFLUENCE fracture RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 250)]	8	[('CHEBI_46662', 'mineral', 20, 'mineral'), ('UBERON_0007023', 'adult organism', 162, 'adults'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]	0	['given bone mineral density (bmd) fracture risk, case–control (13–20)– maternal  fracture risk.']
S146-PMC5426325	PMC5426325	4/2017	S146-PMC5426325	['from systematic review and meta-analysis of randomised controlled trials, THERE IS EVIDENCE that Vitamin D-fortified Foods GENERALLY improve Vitamin D status among both children and Adults in a dose-DEPENDENT manner(57–59).']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 123), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0007023', 'adult organism', 182, 'adults')]	0	['meta-analysis randomised trials, -fortified foods  status among children  dose-dependent manner(57–59).']
S16-PMC5474873	PMC5474873	6/2017	S16-PMC5474873	['Animal studies HAVE SHOWN that deficiency of Prenatal Vitamin D is ASSOCIATED with persistent changes in Adult Brain structure, neurochemistry, and behavior (5,7).']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('GO_0007565', 'female pregnancy', 45, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('UBERON_0000955', 'brain', 111, 'brain')]	0	['animal prenatal  changes  brain structure, neurochemistry, behavior (5,7).']
S19-PMC5521778	PMC5521778	7/2017	S19-PMC5521778	['SIMILARLY, Vitamin A deficiency impairs Alveolar maintenance in the Adult Lung [11].']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('UBERON_0003215', 'alveolus', 40, 'alveolar'), ('UBERON_0007023', 'adult organism', 68, 'adult'), ('UBERON_0002048', 'lung', 74, 'lung')]	0	['similarly,  alveolar maintenance  lung [11].']
S166-PMC5594587	PMC5594587	9/2017	S166-PMC5594587	['periconceptional restriction of maternal Vitamin B and methionine supply LED to altered methylation at Cpg islands in the foetal Sheep Liver and with increased Adult body weight and fatness of the offspring [78].']	[('SUPERFICIAL_RELATIONSHIP', 73)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('SO_0001334', 'hydroxywybutosine', 103, 'CpG'), ('NCBITaxon_10088', 'Mus <genus>', 129, 'sheep'), ('UBERON_0002107', 'liver', 135, 'liver'), ('UBERON_0007023', 'adult organism', 160, 'adult')]	0	['periconceptional maternal  methionine supply altered methylation cpg islands foetal sheep liver  fatness offspring [78].']
S18-PMC5634602	PMC5634602	10/2017	S18-PMC5634602	['this RECOMMENDATION is BASED, IN PART, off of work by priemel et al evaluating bone mineralization defects and Vitamin D deficiency in Iliac Crest bone of Adults [3].']	[('FUTURE_WORK', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 30)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_4300127', 'nuchal crest', 135, 'iliac crest'), ('UBERON_0007023', 'adult organism', 155, 'adults')]	0	['based, part, priemel et al bone mineralization defects  iliac crest bone  [3].']
S135-PMC5679631	PMC5679631	11/2017	S135-PMC5679631	['in a cross sectional analysis of 98 Adults examining enterotype partitioning in RELATION to Nutrient Consumption (Food frequency questionnaire), Vitamin D supplement use and Vitamin D from dairy sources were found to be ASSOCIATED with enterotypes.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 220)]	2	[('UBERON_0007023', 'adult organism', 36, 'adults'), ('CHEBI_33284', 'nutrient', 92, 'nutrient'), ('GO_0007631', 'feeding behavior', 101, 'consumption'), ('CHEBI_33290', 'food', 114, 'food'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]	0	['98  enterotype partitioning nutrient consumption (food frequency questionnaire),  supplement  dairy sources enterotypes.']
S18-PMC5706533	PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]	0	['beyond bone calcium homeostasis,1vitamin metabolites cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions pregnancy (such pre-eclampsia, gestational diabetes), birth outcomes.6concern  sparked proportion individuals throughout world serum/plasma concentrations 25-hydroxyvitamin (25(oh)d),7the circulating  status.8there vitamin pregnant women newborns.7\nin 2010, dietary intakes  canada us institute medicine bone health—particularly young children (for instance, rickets) older  (for instance, osteoporosis).1considerable onto  extraskeletal conditions (versus risks) intakes dietary allowance (600 iu/day children ).1the institute’s higher intakes pregnancy lactation.1a 2016 update cochrane collaboration meta-analysis  pregnancy (versus placebo supplement), however, prenatal  supplementation “may pre-eclampsia, birthweight preterm birth.”6other arms (in participants received  fetal growth910but maternal, fetal, infant outcomes.91011citing 2016 cochrane review,6the world organization antenatal routine  supplementation pregnancy.12dietary supplementation recommendations, however, professional organisations (appendix 1), outcomes, prenatal supplementation, regimens supplement dose (or fortification strategies).']
S157-PMC5706533	PMC5706533	11/2017	S157-PMC5706533	['one of the most ROBUST FINDINGS in our systematic review—which has been PREVIOUSLY REPORTED32—was the beneficial EFFECT of Prenatal Vitamin D on RISK of persistent/recurrent wheeze (or asthma) in offspring, BASED ON data from two large well conducted trials in which wheeze/asthma was the primary outcome.3334this is broadly CONSISTENT with the POSSIBLY positive EFFECT of Vitamin D on severity of illness in Adults with asthma.5before Prenatal Vitamin D CAN be RECOMMENDED as a routine preventive measure against childhood asthma, HOWEVER, FURTHER WORK IS REQUIRED to CLARIFY the minimum effective dose and longer term follow-up to determine IF OBSERVED early EFFECTS on symptoms TRANSLATE into reductions in the incidence of asthma and improvements in Pulmonary function.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 145), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 213), ('INCOMPLETE_EVIDENCE', 325), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 363), ('INCOMPLETE_EVIDENCE', 455), ('FUTURE_WORK', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 532), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 557), ('FUTURE_WORK', 569), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('INCOMPLETE_EVIDENCE', 646), ('SUPERFICIAL_RELATIONSHIP', 661), ('SUPERFICIAL_RELATIONSHIP', 681)]	21	[('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('UBERON_0007023', 'adult organism', 409, 'adults'), ('GO_0007565', 'female pregnancy', 436, 'prenatal'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('UBERON_0002048', 'lung', 754, 'pulmonary')]	0	['one review—which reported32—was prenatal  persistent/recurrent wheeze (or asthma) offspring, wheeze/asthma outcome.3334this positive  illness  asthma.5before prenatal  routine measure childhood asthma, however, minimum dose longer term follow-up symptoms reductions asthma pulmonary function.']
S138-PMC5784894	PMC5784894	1/2018	S138-PMC5784894	['IMPORTANTLY, and for the FIRST TIME, we have DEMONSTRATED that for those with early Life Vitamin D deficiency, the Anabolic response of bone to mechanical loading is reduced in Growing bone, AFFECTING both Cortical and Trabecular Bone, with the EFFECT on Cortical bone persisting into “Adult” Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 191), ('SUPERFICIAL_RELATIONSHIP', 245)]	5	[('UBERON_0000104', 'life cycle', 84, 'life'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 115, 'anabolic'), ('GO_0040007', 'growth', 177, 'growing'), ('UBERON_0001851', 'cortex', 206, 'cortical'), ('UBERON_0002483', 'trabecular bone tissue', 219, 'trabecular bone'), ('UBERON_0001851', 'cortex', 255, 'cortical'), ('UBERON_0007023', 'adult organism', 286, 'adult'), ('UBERON_0000104', 'life cycle', 293, 'life')]	0	['importantly, time, life  deficiency, anabolic response bone mechanical loading bone, cortical trabecular bone, cortical bone persisting “” life.']
S147-PMC5784894	PMC5784894	1/2018	S147-PMC5784894	['OUR FINDINGS SUGGEST a nutritional programming EFFECT of Vitamin D on Growing and Adult bone.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0040007', 'growth', 70, 'growing'), ('UBERON_0007023', 'adult organism', 82, 'adult')]	0	['nutritional programming   bone.']
S191-PMC5784894	PMC5784894	1/2018	S191-PMC5784894	['THIS work THUS establishes Early Life Vitamin D deficiency as a FACTOR that CAN CONTRIBUTE to Adult osteoporosis; offers a POTENTIAL Solution–supplementation of Vitamin D during Pregnancy and infancy; and presents a MODEL system TO IDENTIFY pathways that COULD BE TARGETED in Adult Life to prevent or treat osteoporosis, a GLOBAL health PROBLEM.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 10), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 216), ('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('INCOMPLETE_EVIDENCE', 255), ('FUTURE_WORK', 264), ('IMPORTANT_CONSIDERATION', 323), ('IMPORTANT_CONSIDERATION', 337)]	12	[('UBERON_0001847', 'lobule of pinna', 27, 'early life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_75958', 'solution', 133, 'solution'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('UBERON_0000113', 'post-juvenile adult stage', 276, 'adult life')]	0	['establishes life   osteoporosis; offers solution–supplementation  pregnancy infancy; presents system adult life treat osteoporosis, problem.']
S83-PMC5838372	PMC5838372	3/2018	S83-PMC5838372	['the international association of endocrinology DEFINED a Vitamin D level of 21-29 ng /ml as insufficiency and <20 ng/ml as deficiency in Adults (21).']	[('PROBABLE_UNDERSTANDING', 47)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 137, 'adults')]	0	['international endocrinology  21-29 ng /ml <20 ng/ml  (21).']
S85-PMC5838372	PMC5838372	3/2018	S85-PMC5838372	['the RECOMMENDED value for Serum Vitamin D level is lower in children than Adults.']	[('FUTURE_WORK', 4)]	1	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0007023', 'adult organism', 74, 'adults')]	0	['serum  children .']
S90-PMC5941617	PMC5941617	5/2018	S90-PMC5941617	['children REQUIRE less sunlight exposure than Adults to produce sufficient quantities of Vitamin D, both BECAUSE of their higher body surface-area-to-volume ratio and of their increased capacity to produce Vitamin D [85].']	[('IMPORTANT_CONSIDERATION', 9), ('PROBABLE_UNDERSTANDING', 104)]	2	[('UBERON_0007023', 'adult organism', 45, 'adults'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]	0	['children sunlight exposure  produce quantities higher surface-area-to-volume ratio capacity produce  [85].']
S261-PMC5941617	PMC5941617	5/2018	S261-PMC5941617	['moreover, Vitamin D status was DEMONSTRATED to be a significant DETERMINANT of pbm in young Adults [214,215].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adults')]	0	['moreover,  status pbm young  [214,215].']
S299-PMC5941617	PMC5941617	5/2018	S299-PMC5941617	['for example, no relationship has been FOUND in children and Adults between baseline Vitamin D concentrations and Influenza Virus infection [256].']	[('INCOMPLETE_EVIDENCE', 38)]	1	[('UBERON_0007023', 'adult organism', 60, 'adults'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('NCBITaxon_1', 'root', 113, 'influenza virus')]	0	['example, children  baseline  concentrations influenza virus infection [256].']
S303-PMC5941617	PMC5941617	5/2018	S303-PMC5941617	['SEVERAL STUDIES, mostly in Adults, have also addressed the QUESTION WHETHER Vitamin D supplementation CAN PREVENT OR reduce the severity of upper or lower Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('EXPLICIT_QUESTION', 68), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	7	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]	0	['several studies,  supplementation upper respiratory infections.']
S383-PMC5941617	PMC5941617	5/2018	S383-PMC5941617	['in another STUDY high doses of Vitamin D (100,000\xa0iu as first dose and 50,000\xa0iu/week for 6\xa0months) were administered to 130 patients (children and Adults).']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0007023', 'adult organism', 148, 'adults')]	0	['doses  (100,000\xa0iu dose 50,000\xa0iu/week 6\xa0months) administered 130 patients (children ).']
S480-PMC5941617	PMC5941617	5/2018	S480-PMC5941617	['two meta-analyses CONFIRMED that Vitamin D deficiency was ASSOCIATED with obesity in children, adolescents and Adults irrespective of age, latitude, and cut-offs used to define deficiency [439,440].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adults')]	0	['two meta-analyses  obesity children, adolescents  irrespective age, latitude, cut-offs [439,440].']
S483-PMC5941617	PMC5941617	5/2018	S483-PMC5941617	['ON THE CONTRARY, two meta-analyses enrolling MAINLY Adults SHOWED that Vitamin D supplementation did not decrease adiposity [444,445].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 59)]	3	[('UBERON_0007023', 'adult organism', 52, 'adults'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]	0	['contrary, meta-analyses enrolling   supplementation decrease adiposity [444,445].']
S501-PMC5941617	PMC5941617	5/2018	S501-PMC5941617	['finally, two RECENT meta-analyses SHOWED that Vitamin D supplementation had no significant effect on Glucose and Insulin Metabolism [461] and on changes in the concentrations of inflammatory BIOMARKERS (C-Reactive Protein, tumor necrosis factor alpha, Il-6) in obese and overweight adolescents and Adults [462].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17234', 'glucose', 101, 'glucose'), ('GO_0007369', 'gastrulation', 101, 'glucose ...'), ('GO_1901142', 'insulin metabolic process', 113, 'insulin metabolism'), ('PR_000045358', 'insulin family protein', 113, 'insulin'), ('PR_000005890', 'crooked neck-like protein 1', 203, 'C-reactive protein'), ('PR_000001470', 'interleukin-28B', 252, 'IL-6'), ('UBERON_0007023', 'adult organism', 298, 'adults')]	0	['finally, meta-analyses  supplementation glucose insulin metabolism [461] changes concentrations inflammatory (c-reactive protein, tumor necrosis alpha, il-6) obese overweight adolescents  [462].']
S536-PMC5941617	PMC5941617	5/2018	S536-PMC5941617	['meta-analyses assessing the EFFECT of Vitamin D supplementation in depressed Adults FOUNDED CONFLICTING results [495–497].']	[('SUPERFICIAL_RELATIONSHIP', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 77, 'adults')]	0	['meta-analyses  supplementation depressed  results [495–497].']
S67-PMC5956785	PMC5956785	5/2018	S67-PMC5956785	['the society RECOMMENDS that AT-RISK populations, including “obese children and Adults and children and Adults on Anticonvulsant medications, Glucocorticoids, antifungals such as Ketoconazole, and medications for acquired immune deficiency syndrome be given at least two to three times more Vitamin D for their age group to satisfy their body’s Vitamin D REQUIREMENT” [20].']	[('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 354)]	3	[('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0007023', 'adult organism', 103, 'adults'), ('CHEBI_35624', 'azaspiro compound', 113, 'anticonvulsant'), ('CHEBI_36597', 'phthalazine', 141, 'glucocorticoids'), ('CHEBI_47519', 'ketoconazole', 178, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]	0	['society populations, “obese children  children  anticonvulsant medications, glucocorticoids, antifungals ketoconazole, medications acquired immune syndrome three times  age body’s  requirement” [20].']
S2617-PMC4113768	PMC4113768	7/2014	S2617-PMC4113768	['methods: in a double-blind Placebo-controlled randomised trial, 340 Adults (172 from cambridge and 168 from london) at INCREASED RISK of t2d (non-diabetic hyperglycaemia or positive diabetes risk score) were randomised into one of three groups of oral therapy: placebo, 100,000 iu Vitamin D2(Ergocalciferol) or 100,000 iu Vitamin D3(Cholecalciferol) at monthly intervals for four months.']	[('IMPORTANT_CONSIDERATION', 119)]	1	[('CHEBI_26130', 'biological pigment', 27, 'placebo'), ('UBERON_0007023', 'adult organism', 68, 'adults'), ('CHEBI_28934', 'vitamin D2', 281, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 281, 'Vitamin D2'), ('CHEBI_4910', 'etomidate', 292, 'ergocalciferol'), ('CHEBI_33237', 'vitamin D4', 322, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 322, 'Vitamin D3'), ('CHEBI_52550', 'theopalauamide', 333, 'cholecalciferol')]	0	['methods: double-blind placebo-controlled randomised trial, 340  (172 cambridge 168 london) t2d (non-diabetic hyperglycaemia positive diabetes score) randomised three oral therapy: placebo, 100,000 iu (ergocalciferol) 100,000 iu vitamin d3(cholecalciferol) monthly intervals four months.']
S20-PMC5273824	PMC5273824	1/2017	S20-PMC5273824	['study HAS SHOWN that exposing edible Mushroom to ultraviolet b light COULD increase its Vitamin D2 content and raise Serum 25-Oh vitd2 in healthy Adults [2,3].']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 69)]	2	[('NCBITaxon_10088', 'Mus <genus>', 37, 'mushroom'), ('CHEBI_28934', 'vitamin D2', 88, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 88, 'Vitamin D2'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 123, '25-OH'), ('UBERON_0007023', 'adult organism', 146, 'adults')]	0	['study exposing edible mushroom ultraviolet b increase  content serum 25-oh vitd2 healthy  [2,3].']
